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Aneuploidy, the state of having a chromosome number different from a multiple of 
the haploid number, has been associated with diseases and developmental disorders.  The 
role of aneuploidy in human disease pathology, especially in cancer, has been a subject of 
much attention and debate over the last century due to the intrinsic complexity of the 
phenomena and experimental challenges. Aneuploidy and epigenetic alterations have long 
been associated with carcinogenesis, but it was unknown whether aneuploidy could disrupt 
the epigenetic states required for cellular differentiation.  
In my PhD studies, first I did a literature review on the contribution of studies in 
yeast to current knowledge about aneuploidy with special emphasis on experimental 
features making yeast a simpler and efficient model to investigate the complex questions 
in the field of aneuploidy (Chapter 2). Over the last decade, yeast has been an invaluable 
model for driving discoveries about the genetic and molecular aspects of aneuploidy. 
Understanding of aneuploidy has been significantly improved owing to the methods for 
selectively generating aneuploid yeast strains without causing other genetic changes, 
techniques for detecting aneuploidy, and cutting-edge genetics and ‘omics’ approaches. In 
this review, we discuss the contribution of studies in yeast to current knowledge about 
aneuploidy.  Special emphasis is placed on experimental features which make yeast a 
simpler and efficient model to investigate the complex questions in the field of aneuploidy. 
In second part (Chapters 3 and 4), I performed genetic analyses revealing that 
purely quantitative changes in the relative copy number of chromosomes can be sufficient 
to disrupt the epigenetic mechanisms that define the cells' differentiated state. In this study, 
we found that ~3% of random aneuploid karyotypes in yeast disrupt the stable inheritance 
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of silenced chromatin during cell proliferation. Karyotype analysis revealed that this 
phenotype was significantly correlated with gains of chromosomes III and X. Chromosome 
X disomy alone was sufficient to disrupt chromatin silencing and yeast mating-type 
identity as indicated by a lack of growth response to pheromone. The silencing defect was 
not limited to cryptic mating type loci and was associated with broad changes in histone 
modifications and chromatin localization of Sir2 histone deacetylase. The chromatin-
silencing defect of disome X can be partially recapitulated by an extra copy of several 
genes on chromosome X. These results suggest that aneuploidy can directly cause 
epigenetic instability and disrupt cellular differentiation. 
Our findings provide the causal evidence that aneuploidy is a source of epigenetic 
instability. It may thus be worth exploring a potential linkage between epigenetic 
dysregulation and chromosome copy number alterations observed in cancer. The 
aneuploidy-induced changes in heterochromatin inheritance and histone-modification 
landscape may be an important mechanism by which chromosomal instability drives large-
scale phenotypic variability during tumor evolution.  
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Eukaryotic cell division is a highly complex and regulated process involving a 
robust surveillance mechanism, called mitotic checkpoint (or spindle assembly 
checkpoint), to ensure the fidelity of chromosome segregation. Alterations in the mitotic 
checkpoint and components of the chromosome segregation machinery often result in an 
unbalanced genomic state called aneuploidy (Aguilera and Gomez-Gonzalez 2008).  
Aneuploidy exists in somatic cells such as normal human brain (Rehen, Yung et al. 2005) 
and liver (Duncan 2013).  Aneuploidy at the organismal level in humans generally causes 
embryonic lethality; however, a few viable aneuploidies cause genetic disorders such as 
Down's syndrome (trisomy 21) and Edwards syndrome (trisomy 18) (Nagaoka, Hassold et 
al. 2012).  Aneuploidy has also been recognized as a common characteristic of cancer cells 
for more than 100 years (Boveri 1914, Holland and Cleveland 2009). Cancer is a dynamic 
evolutionary system where cells that can survive are continuously selected for, against a 
backdrop of restrictive conditions, ranging from tissue-specific growth regulators to 
various drug treatments. The adaptability and evolvability of cancer cells could be 
attributed to their genomic diversity conferred by aneuploidy and other forms of mutations 
(Nowell 1976, Pavelka, Rancati et al. 2010, Thomas, Fisher et al. 2013).  
The implications of aneuploidy in cancer, drug resistance, pathogenicity as well as 
the existence of aneuploidy in normal human brain and liver are the subjects of recent 
attention.  Considering the continual karyotypic changes and heterogeneity in aneuploid 
cell populations and the difficulty of separating the effect of aneuploidy from other types 
of genetic aberrations, the molecular mechanisms underlying diverse phenotypic effects of 
aneuploidy remain poorly understood.  Despite the large effort devoted to the elucidation 
of the causes and consequences of aneuploidy, it is hindered by inherent scientific and 
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technical difficulties. (McGranahan, Burrell et al. 2012).  The study of aneuploidy in cancer 
cells is complicated by the presence of numerous point mutations and a variety of other 
chromosomal abnormalities such as inversions and translocations. In addition, 
investigation of physiological and pathological effects of aneuploidy in multi-cellular 
organisms is limited by difficulties in generating isogenic and stable aneuploid cell 
populations. Adding to these difficulties are the low throughput, labor intensive and 
expensive methods currently available for accurate karyotyping.  These experimental 
challenges underscore the need for model organisms and more efficient experimental 
techniques to facilitate the study of the diverse aspects of aneuploidy at the cellular and 
molecular levels. 
The histone modification landscape and the associated open or closed (silenced) 
chromatin conformations regulate access to the genetic information by transcriptional 
machinery and provide a mechanism for the establishment and maintenance of stable 
epigenetic states in well-differentiated cells and tissues (Jaenisch and Bird 2003). 
Alterations in epigenetic modifications have been recognized as a key step in the initiation 
and progression of cancer whereby quiescent or slowly-dividing somatic cells escape their 
normal differentiated state and undergo precocious proliferation. (Feinberg, Ohlsson et al. 
2006, Timp and Feinberg 2013, Morgan and Shilatifard 2015). However, the mechanisms 
underlying changes in the epigenetic-state associated with neoplastic transformation have 
not been fully elucidated.  
Cancer progression is also associated with a wide range of genetic abnormalities, 
from mutations of single genes to structural or copy number alterations on the 
chromosomal level. Aneuploidy, an unbalanced genomic state in which the number of 
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chromosomes deviates from a multiple of the haploid complement, is found in over 90% 
of human solid tumors and 50% of hematopoietic malignancies (Mitelman, Johansson et 
al. 2012). Although the association of aneuploidy with cancer was noted more than a 
century ago, its contribution to cancer progression has only been actively explored in recent 
years (Boveri 1914, Holland and Cleveland 2012). Aneuploidy is correlated with complex 
patterns of altered gene transcription (Upender, Habermann et al. 2004, Ried, Hu et al. 
2012), but its potential impact on the epigenetic state of cancer cells remains unclear due 
to the co-existence of the other genetic alterations in highly complex and unstable cancer 
genomes.   
In my PhD studies, first I did a literature review on the contribution of studies in 
yeast to current knowledge about aneuploidy with special emphasis on experimental 
features making yeast a simpler and efficient model to investigate the complex questions 
in the field of aneuploidy. In second part, I performed genetic analyses revealing that purely 
quantitative changes in the relative copy number of chromosomes can be sufficient to 
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Aneuploidy, the state of having a chromosome number different from a multiple of 
the haploid number, has been associated with diseases and developmental disorders.  The 
role of aneuploidy in human disease pathology, especially in cancer, has been a subject of 
much attention and debate over the last century due to the intrinsic complexity of the 
phenomena and experimental challenges.  Over the last decade, yeast has been an 
invaluable model for driving discoveries about the genetic and molecular aspects of 
aneuploidy. Understanding of aneuploidy has been significantly improved owing to the 
methods for selectively generating aneuploid yeast strains without causing other genetic 
changes, techniques for detecting aneuploidy, and cutting-edge genetics and ‘omics’ 
approaches. In this review, we discuss the contribution of studies in yeast to current 
knowledge about aneuploidy.  Special emphasis is placed on experimental features which 











Simple model organism, such as the budding yeast S. cerevisiae has emerged as a 
robust and versatile model system for studying the effects of genetic alterations (Botstein 
and Fink 2011).  A unicellular eukaryote, the budding yeast, is particularly suitable for 
studying the effects of aneuploidy on cellular physiology because of its small haploid 
genome, divided into sixteen chromosomes, thus a well tolerance to aneuploidy.  In 
addition, it is possible to generate isogenic aneuploid yeast strains without causing other 
genomic changes.  Yeast studies of aneuploidy using genomics and proteomics approaches 
have significantly improved understanding of the causes and consequences of aneuploidy.  
Many yeast biochemical pathways are conserved across the higher eukaryotic species, 
justifying the use of yeast as a simple model system for studying complex biological 
processes.  In this review, we summarize the contribution of studies in yeast to the current 
understanding of the causes and consequences of aneuploidy.  A special emphasis is given 
to the methods for the generation of a variety of aneuploid yeast strains and karyotyping.  
 
2.3 Causes of aneuploidy in yeast 
Chromosome segregation errors are the cause of aneuploidy.  Normally, the 
frequency of spontaneous chromosome gain or loss in laboratory strains of budding yeast 
is low. In standard laboratory conditions, the spontaneous loss rate of chromosome V in 
diploid budding yeast S. cerevisiae is around 2-8 per 106 cell divisions (Hartwell and Smith 
1985, Klein 2001).  Proper functioning of the mitotic spindle apparatus and the correct 
structural organization of the duplicated chromosomes are essential for fidelity of 
chromosome segregation in mitosis (Page and Snyder 1993).  The spindle assembly 
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checkpoint serves as a surveillance mechanism to prevent chromosome missegregation in 
mitosis (Musacchio and Salmon 2007).  Defects in any of these biological processes could 
compromise the accuracy of chromosome segregation producing an aneuploid progeny.  
Genetic screens in budding yeast have shown at least 10% of its genome is involved in the 
maintenance of chromosome stability (Ouspenski, Elledge et al. 1999, Smith, Hwang et al. 
2004, Kanellis, Gagliardi et al. 2007, Yuen, Warren et al. 2007, Stirling, Bloom et al. 2011).  
These genes are referred as CIN genes since their mutations cause chromosome instability 
(CIN).  Many of these CIN genes are known to function in processes such as kinetochore 
and spindle microtubule interaction,  DNA replication, repair, condensation, and the 
spindle assembly checkpoint (Stirling, Bloom et al. 2011).  It is essential to distinguish true 
CIN genes from genes whose mutations may not necessarily cause CIN, but pose a strong 
selection for certain aneuploid karyotypes that help alleviate growth deficiencies caused 
by gene mutations (Hughes, Roberts et al. 2000, Rancati, Pavelka et al. 2008).  For 
example, big colonies isolated from rnr1Δ strain were found to have an extra copy of 
chromosome IX.  This could be the result of a selection for the improved growth by 
increasing dosage of a paralogue gene RNR3 on chromosome IX, but, the deletion of RNR1 
may not necessarily cause CIN. 
Environmental stress has also been shown to induce chromosome missegregation 
in yeast.  Exposure of the pathogenic yeast, C. albicans, to heat stress and antifungal drugs 
elevates the frequency of chromosome loss (Forche, Abbey et al. 2011).  Also in C. 
neoformans, high-dose of fluconazole treatment has been suggested to cause chromosomal 
instability (Sionov, Lee et al. 2010).  It was noticed that the high frequency (0.3 to 0.6%) 
at which aneuploidy occurs in C. neoformans under fluconazole stress could not be the 
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result of spontaneous aneuploidy formation.  A recent study investigated how diverse stress 
conditions affect CIN in budding yeast through monitoring the loss of a minichromosome, 
many stress conditions were shown to promote CIN (Chen, Bradford et al. 2012).  In 
particular, inhibition of the Hsp90 chaperone by various means markedly increased the loss 
rate of artificial chromosome compared to the stress-free culture condition.  This effect was 
linked to a crucial role for Hsp90 in kinetochore assembly.  
Another route to aneuploidy in yeast is through polyploidization.  Meiosis of 
triploid or pentaploid cells gives rise to an almost exclusively aneuploid progeny.  Mitosis 
of polyploid cells is also known to be error-prone.  Tetraploid S. cerevisiae loses 
chromosomes at a higher rate than diploid (Mayer and Aguilera 1990).  This is thought to 
be caused by an increased incidence of syntelic (mono-polar) kinetochore attachments, 
which arise due to an altered spindle geometry in tetraploids (Storchova, Breneman et al. 
2006).  Tetraploid C. albicans can undergo dramatic chromosome loss when growing on 
S. cerevisiae 'pre-sporulation' media and sorbose media.  This often results in a diploid or 
near-diploid aneuploid progeny (Bennett and Johnson 2003).  
 
2.4 The effect of aneuploidy on gene expression 
Recent studies in yeast suggest that phenotypic effects of aneuploidy are directly 
linked to changes in the expression of many genes (Torres, Sokolsky et al. 2007, Rancati, 
Pavelka et al. 2008, Pavelka, Rancati et al. 2010, Chen, Bradford et al. 2012).  There are 
several possible mechanisms by which aneuploidy could affect gene expression and 
phenotype (Birchler 2010, Pavelka, Rancati et al. 2010).   
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The effects of aneuploidy on gene expression can be divided as those proportional 
to DNA dosage, known as inlier changes; or those far beyond the DNA dosage, known as 
outlier changes.  The inlier gene expression change is often moderate as it is chromosome 
copy-number driven and occurs to most genes encoded on aneuploid chromosomes.  For 
example, in haploid aneuploid strains carrying an extra copy of one of the sixteen S. 
cerevisiae chromosomes (disomies), expression of most of the genes on an aneuploid 
chromosome was found to be increased two-fold as compared to the haploid control 
(Torres, Sokolsky et al. 2007).  A similar observation came from analysis of a set of 
relatively stable aneuploid S. cerevisiae strains generated by triploid meiosis, where the 
relative level of mRNA (compared to euploid) for most of the genes encoded on aneuploid 
chromosomes directly correlates to the relative gene copy-number (Pavelka, Rancati et al. 
2010).  A direct DNA dosage effect on gene expression was observed in 23 aneuploid 
strains from a yeast deletion collection (Sheltzer, Torres et al. 2012).  In other studies, such 
as in the case of fluconazole-resistant C. albicans isolates, the RNA expression change 
(compared to euploid) was found to correlate with DNA copy-number change 
(Bouchonville, Forche et al. 2009). 
However, the impact of aneuploidy on gene expression is not limited to a simple 
dosage effect.  Observed in every aneuploid yeast strain analyzed in our studies, there were 
a small number of genes with expression changes greater than the several standard 
deviations from the average chromosome expression change.  These genes with outlier 
expression changes are distributed throughout the genome (Rancati, Pavelka et al. 2008, 
Pavelka, Rancati et al. 2010).  Yeast transcriptional network analysis found that outlier 
genes are enriched as functional targets of the regulatory factors encoded on aneuploid 
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chromosomes.  This implies that a substantial subset of outlier gene expression changes 
can be viewed as a downstream consequence of the inlier gene expression changes due to 
karyotype changes (Rancati, Pavelka et al. 2008). 
Do apparent effects of aneuploidy on transcriptome translate to similar effects on 
the proteome?  In S. cerevisiae aneuploid strains generated from triploid meiosis, 
quantitative proteomic analysis using multidimensional protein identification technology 
(MudPIT) revealed that the relative expression of most proteins encoded on aneuploid 
chromosomes scaled proportionally to DNA and mRNA dosage.  Using the method of 
stable isotope labeling by amino acids in cell culture (SILAC), proteomic analysis 
performed in disomic budding yeast aneuploid strains arrived at a similar conclusion.  
However, in the latter study, approximately 20% of the proteins analyzed did not show a 
proportional increase in accordance with the chromosome number and the gene expression 
change, leading the authors to conclude that dosage compensation occurs in aneuploid 
yeast only for some genes.  Further analysis of proteins that did not follow the trend of 
copy-number change showed that a majority of these proteins were components of various 
protein complexes (Torres, Dephoure et al. 2010). Although the mechanism underlying the 
observed dosage compensation remains to be elucidated, it may have something to do with 
reduced stability of proteins when they are not incorporated in their native complex.  
 
2.5 Phenotypic effects of aneuploidy 
The euploid chromosome number in a given species is an optimum acquired during 
evolution of that species.  Generally, aneuploidy is not well tolerated in nature, manifested 
by impaired fitness at the cellular and organismal level.  Systematic analysis of budding 
12 
 
yeast disomic strains showed slower cell proliferation under normal conditions compared 
to euploid strains (Torres, Sokolsky et al. 2007).  Similar poor proliferative capacity under 
standard growth parameters is exhibited by aneuploid strains generated from triploid 
meiosis in S. cerevisiae and S. pombe (Niwa, Tange et al. 2006, Pavelka, Rancati et al. 
2010). Studies in S. cerevisiae and S. pombe aneuploid strains have shown that aneuploidy 
causes delay in the G1 phase of their cell cycle. (Niwa, Tange et al. 2006, Torres, Sokolsky 
et al. 2007, Pavelka, Rancati et al. 2010).  Recent study has characterized the G1 delay in 
aneuploid cells as a consequence of slower accumulation of G1 cyclins (Thorburn, 
Gonzalez et al. 2013).  
Even though aneuploidy impairs growth and fitness under stress-free conditions, its 
adaptive value becomes apparent under conditions detrimental to euploid yeast strains.  
Emerging evidence suggests that aneuploidy is a form of genome alteration that promotes 
adaptive evolution of cells in response to harsh environments or genetic perturbations 
(Table 1).  For example, certain aneuploid karyotypes in budding yeast enable them to 
overcome nutrient limitations such as low glucose, high-phosphate, or sulphate media 
(Gresham, Desai et al. 2008).  In pathogenic fungi, aneuploidy is known to be widely 
associated with drug resistance and increased pathogenicity (Polakova, Blume et al. 2009, 
Sionov, Chang et al. 2009, Hu, Wang et al. 2011, Silva, Negri et al. 2012) (Morrow and 
Fraser 2013). 
The adaptive benefits of aneuploidy can be attributed to the altered dosage of single 
or multiple genes on an aneuploid chromosome.  For example, in the systematic analysis 
of 38 aneuploid S. cerevisiae strains, some aneuploid variants showed improved fitness 
compared to parental euploid strains under adverse conditions such as treatment with the 
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tumorigenic compound 4-nitroquinoline-oxide (4-NQO).  The improved fitness in the 
presence of 4-NQO was attributed to the increased expression of the gene ATR1, whose 
copy-number was increased through the gain of chromosome XIII (Pavelka, Rancati et al. 
2010).  ATR1 encodes a transporter protein known to confer 4-NQO-resistance when 
overexpressed (Mack, Gompel-Klein et al. 1988).  Another example is radicicol resistance 
associated with chromosome XV gain in S. cerevisiae.  This was attributed to the 
synergistic effect of the increased dosage of two genes, STI1 and PDR5 (encoding an 
Hsp90 co-chaperone and a drug pump, respectively), encoded on chromosome XV (Chen, 
Bradford et al. 2012).  
A very remarkable adaptive effect of aneuploidy in budding yeast was observed in 
the case of myo1∆.  MYO1 encodes the myosin-II motor protein that normally drives bud 
neck constriction during cytokinesis.  Whereas deletion of MYO1 results in massive 
cytokinesis failure and lethality in most cells (Tolliday, Pitcher et al. 2003), a few myo1∆ 
survivors were able to evolve alternative cytokinesis mechanisms through changes in 
chromosome stoichiometry.  One class of the myo1∆ “evolvants” restores cytokinesis by 
cell wall thickening in the bud neck region, upregulating the set of genes involved in the 
cell wall biogenesis.  Located on both euploid and aneuploid chromosomes, many of these 
showed outlier gene expression (Rancati, Pavelka et al. 2008).  Further analysis 
demonstrated that these gene expression changes were due to extra copies of two genes - 
RLM1 (a transcription factor) and MKK2 (activator of RLM1) located on chromosome XVI.  
By simply introducing extra copies of RLM1 and MKK2 into myo1Δ the evolved 
mechanism of cytokinesis was recapitulated.  Well-annotated functional genomics data in 
yeast have been particularly helpful in unraveling the molecular mechanisms by which an 
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aneuploid karyotype confers a particular phenotype. In aneuploid cancer cells, identifying 
specific genes on an aneuploid chromosome that could account for the growth advantage 
is more challenging. 
 
2.6 Aneuploidy and chromosomal instability in yeast 
While aneuploidy is a product of chromosome instability, it also correlates with 
elevated chromosomal instability observed as gaining or losing chromosomes at a high 
frequency.  This vicious cycle is thought to underlie cancer “genome chaos” (Potapova, 
Zhu et al. 2013).  Studying the relationship between aneuploidy and chromosomal 
instability in cancer cells is complicated by the presence of a variety of other genetic 
changes.  Therefore, a simple and genetically tractable model system, such as yeast, holds 
many advantages for studying this phenomenon.  The observation of chromosomal 
instability in aneuploid yeast cells was made more than four decades ago (Parry and Cox 
1970).  Extra chromosomes in aneuploid strains generated from triploid meiosis were found 
to have higher loss rate, generating karyotypically diverse cell populations (St Charles, 
Hamilton et al. 2010).  High rates of chromosomal instability were also seen in aneuploid 
C. albicans strains exposed to stresses of routine experimental techniques such as 
transformation (Bouchonville, Forche et al. 2009).  Recently, the link between 
chromosomal instability and aneuploidy was addressed systematically using several 
approaches.  The rate of chromosome missegregation inferred from the loss of artificial 
chromosome was found to increase in 9 out of 13 yeast disomic strains (Sheltzer, Blank et 
al. 2011).  Similarly, monosomic budding yeast cells showed an increased chromosomal 
instability and were predisposed to return to a diploid karyotype when cultured under 
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standard conditions (Waghmare and Bruschi 2005, Chen, Bradford et al. 2012).  For 
example, chromosome XVI monosomic strain was found to be karyotypically unstable 
under normal conditions but when maintained under tunicamycin selection, it appeared 
stable in terms of population homogeneity.  This underscores the challenge of finding the 
right conditions to separate selection vs. intrinsic genomic stability (Chen, Bradford et al. 
2012).  A recent study demonstrated a positive correlation of chromosome instability with 
the degree of aneuploidy as well as with the presence of specific aneuploid chromosomes 
and dosage imbalance between specific chromosome pairs (Zhu, Pavelka et al. 2012).  The 
“genome chaos” created by aneuploidy-associated chromosome instability may be a 
powerful mechanism for the rapid generation of karyotypic diversity in the population, 
providing the substrate for evolutionary selection of adaptive genomes (Nowell 1976, 
Merlo, Pepper et al. 2006, Selmecki, Forche et al. 2006, Rancati, Pavelka et al. 2008, 
Selmecki, Dulmage et al. 2009, Chen, Bradford et al. 2012). 
 
2.7 Experimental approaches in the study of aneuploidy using yeasts as a model 
organism. 
2.7.1 Methods for generating aneuploidy in yeast 
Several different methods have been developed to generate aneuploidy in yeast.  
One method for obtaining aneuploid budding yeast strains with random chromosome 
stoichiometry is treatment with the low concentration of radicicol, which disrupts the 
normal kinetochore function (Chen, Bradford et al. 2012).  When a diploid strain was 
treated with 20 μg/ml radicicol for two days, about one third of the population was found 
to be an aneuploid with diverse karyotypes (Chen, Bradford et al. 2012).  This is one simple 
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way to generate yeast aneuploid strains as it does not require a complicated genetic 
manipulation.  Another efficient way for obtaining random aneuploid strains is by 
sporulation of polyploid strains with an odd ploidy.  This method takes advantage of the 
fact that in triploid and pentaploid strains, homologous chromosomes segregate randomly 
in the first meiotic division thereby giving rise to mostly aneuploid spores (Fig. 1a).  It has 
been used successfully in generating budding yeast strains with diverse karyotypes and for 
generating fission yeast with disomy III (Niwa and Yanagida 1985, Niwa, Tange et al. 
2006, Rancati, Pavelka et al. 2008, Charles, Hamilton et al. 2010, Pavelka, Rancati et al. 
2010).  As discussed above, aneuploid strains derived from this method have various levels 
of karyotypic instability; relatively stable karyotypes could be obtained by screening for 
strains with low level of intra-population karyotype heterogeneity (Pavelka, Rancati et al. 
2010, Zhu, Pavelka et al. 2012).  
Defined aneuploid strains with simple karyotypes could be obtained by two other 
means.  One is through the use of a conditional centromere where a GAL1 promoter is 
inserted adjacent to centromere sequences (Hill and Bloom 1987, Reid, Sunjevaric et al. 
2008, Anders, Kudrna et al. 2009).  The transcriptional induction of the promoter abrogates 
centromere function and causes chromosome nondisjunction (Fig. 1b).  Both disomies and 
monosomies have been isolated using this approach.  Another method for isolating 
disomies is through chromoduction (Conde and Fink 1976, Nilsson-Tillgren, Petersen et 
al. 1980, Torres, Sokolsky et al. 2007).  This method utilizes the rare chromosome transfer 
between two haploid strains during abortive mating (Fig. 1c).  The disomic chromosome 
can be selected by introducing selectable markers to both homologs, although this selection 
prevents only the loss but not the gain of disomic or any other yeast chromosomes in the 
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strain. Strains with complex and simple aneuploid karyotypes have proven to be 
complementary in the study of the aneuploidy.  Of practical note, because of the intrinsic 
instability of aneuploid strains, it is essential to frequently check the karyotype (see 
methods below) of the strains during passages and especially after revival from frozen 
stocks. 
2.7.2 Methods for detection of aneuploidy in yeast 
Recently developed genomic analysis techniques have advanced our ability to 
monitor karyotype changes and determine chromosome copy-numbers in yeast.  Here we 
discuss various approaches used to detect whole chromosomal aneuploidy.  These 
approaches include electrophoresis-based methods, flow cytometry, array-comparative 
genomic hybridization (a-CGH), qPCR karyotyping and Next-Generation sequencing. 
Besides the determination of chromosome copy-number variations, these karyotyping 
methods allow assessment of the size of chromosomes, genome size and ploidy level, study 
of genome dynamics, identification of gross chromosomal rearrangements and associated 
chromosomal polymorphism.  Considering the scope of this article, these methods are 
focused for karyotyping yeast cells but are generally applicable to other eukaryotic 
organisms as well. 
Electrophoresis based karyotyping: Pulsed-field gel electrophoresis (PFGE) has 
been widely used in epidemiological studies of pathogenic yeasts and optimized for the 
separation of C. albicans and S. cerevisiae chromosomes (Doi, Homma et al. 1992, 
Maringele and Lydall 2006).  Although PFGE has been mainly used to detect gross 
chromosomal rearrangements (Pardo and Aguilera 2012, Reis, Batista et al. 2012), 
quantitative southern blotting after the separation of chromosomes by PFGE can be used 
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to detect alterations in the relative copy-number of different chromosomes (Chen, Magee 
et al. 2004, Bouchonville, Forche et al. 2009).  Detailed protocol can be obtained from the 
cited reference (O'Brien, Udo et al. 2006). Another method for chromosome copy-number 
determination is the multiplex PCR method with micro-capillary electrophoresis where 
chromosomal DNA is separated based upon size to charge ratio in the interior of a small 
electrolyte filled capillary.  Further, using a bioanalyzer, aneuploidy in the test sample can 
be determined by the relative ratio of the peak height of the test and euploid control DNA 
fragments in the chromatogram (Arbour, Epp et al. 2009). 
Flow cytometry:  Flow cytometry is a convenient and least expensive method for 
assessment of ploidy variation in the population.  This technique provides an overview of 
cellular DNA content rather than information on the gain or loss of specific chromosomes.  
Estimation of DNA content is based on the use of an intercalating fluorescent dye such as 
SYTOX® Green dye, that binds proportionally to DNA, allowing estimation of DNA cell 
cycle distribution and ploidy for thousands of cells per second. This method has been 
optimized and routinely used for both Candida and Saccharomyces species. Detailed 
protocol can be obtained from cited reference (Haase and Lew 1997, Ibrahim, Magee et al. 
2005, Darzynkiewicz, Halicka et al. 2010, Zhu, Pavelka et al. 2012). This technique is also 
highly adaptable to a high-throughput format. 
Array-comparative genomic hybridization (a-CGH):  Whereas, electrophoresis and 
flow cytometry-based methods allow for a rapid detection of aneuploid genome, a-CGH 
provides a high-resolution map of both DNA copy-number changes and possible structural 
chromosomal aberrations (Pinkel and Albertson 2005).  In typical a-CGH measurements, 
total genomic DNA from a test sample and a normal reference sample are hybridized to an 
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array of fluorescent probes the spanning the entire genome.  The fluorescence intensity is 
then measured and compared to reference samples, indicating chromosome copy-number 
changes as well as the gain or loss of specific loci.  A variety of studies have used this 
method to monitor whole and segmental chromosomal aneuploidy (Pinkel and Albertson 
2005, Torres, Sokolsky et al. 2007, Rancati, Pavelka et al. 2008, Arbour, Epp et al. 2009, 
Selmecki, Dulmage et al. 2009, Pavelka, Rancati et al. 2010, Chen, Bradford et al. 2012).  
Detailed protocol can be referred from cited reference (Dion and Brown 2009).   
qPCR-karyotyping:   Although a-CGH offers a high resolution map of the genome; 
its limitations include low-throughput, high costs and cumbersome sample preparation. 
qPCR-based karyotyping is a more convenient and high-throughput, although less accurate 
method for monitoring whole chromosome aneuploidy.  The existing protocol employs 
primers recognizing a non-coding region of each arm of a chromosome and the amplified 
PCR product can be detected using several fluorescent intercalating dyes, such as SYBR® 
Green in a real-time manner.  With the use of liquid handling robotics, the entire procedure, 
from genomic DNA extraction to the q-PCR, can be easily performed in a high-throughput 
format.  This method has been used successfully in several yeast aneuploidy studies 
(Pavelka, Rancati et al. 2010, Chen, Bradford et al. 2012, Zhu, Pavelka et al. 2012).  
Next Generation sequencing (NGS)-karyotyping:  NGS-karyotyping is based upon 
massive parallel sequencing of the whole yeast genome. In brief, genomic DNA is used to 
create a library of smaller fragments, and then sequenced by millions of parallel reactions 
generating nucleotide reads.  The differential coverage abundance across segments of the 
reference genome is used to detect chromosome copy-number variation (Dudarewicz, 
Holzgreve et al. 2005, Didelot, Bowden et al. 2012, Nekrutenko and Taylor 2012).  Beside 
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copy-number information, determination of single-nucleotide polymorphisms (SNP) by 
sequencing also allows consideration of whether the presence SNP contributes to 
phenotypic changes associated with an aneuploid strain. (Rancati, Pavelka et al. 2008, 
Pavelka, Rancati et al. 2010, Torres, Dephoure et al. 2010).  The throughput of Next 
Generation sequencing machines has improved dramatically over the past few years.  A 
recent study revealed the genotyping of 1000 yeast strains, at the cost of less than 15 euros 
per sample, in a few weeks (Wilkening, Tekkedil et al. 2013).  Also due to the recent 
development of single-cell whole genome amplification of an individual human cell, high 
coverage single-cell sequencing is now possible (Zong, Lu et al. 2012).  
 
2.8 Future Perspective 
In this review, we discussed recent progress in understanding of the causes and 
consequences of aneuploidy through studies in yeast.  We also highlighted the methods to 
generate and detect aneuploidy in yeast.  Yeast has proven to be a useful model in studying 
aneuploidy on account of it’s the powerful genetics. For instance, the gain of chromosome 
XVI converts a budding yeast colony from ‘fluffy’ to ‘smooth’ morphology.  Further, the 
gene responsible for the phenotypic switch was easily identified (Tan, Hays et al. 2013).  
This exemplifies the benefit of a well annotated functional genomics data and plasmid 
library of yeast genome (Hvorecny and Prelich 2010)  in unraveling the molecular 
mechanism by which an aneuploid karyotype confers a particular phenotype. 
However, many questions remain unanswered.  For example, as a large portion of 
yeast CIN genes involved in cellular pathways are not connected to chromosome stability, 
additional mechanisms have yet to be identified that would lead to aneuploidy (Stirling, 
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Bloom et al. 2011).  Existing data has clearly demonstrated the adaptive potential of 
aneuploidy under acute stress, but whether aneuploidy could contribute to long term 
adaptive evolution is less clear.  A recent experimental evolution study suggested that 
aneuploidy per se might not serve as a stable and sustainable evolutionary solution (Yona, 
Manor et al. 2012).  Yona et al. observed that when diploid budding yeast growing under 
heat and high pH conditions, aneuploids were observed first but were eventually replaced 
by gene mutations.  Thus, aneuploidy may be a quick and rough fix under strong selective 
pressure, allowing sufficient propagation of the population for the emergence of adaptive 
mutations with less fitness cost than aneuploidy.  Giving the constantly changing 
environment where unicellular organisms live, it is tempting to speculate that natural 
selection might favor the evolution of mechanisms that would modulate chromosome 
segregation fidelity based on the presence of environmental stress, such as critically 
involving a stress-handling chaperone (Hsp90) in kinetochore function.  
Another key question is to what extent the knowledge we have gained about 
aneuploidy in yeast can be applied to multicellular organisms?  As chromosome 
segregation is a highly conserved cellular process in eukaryotes, it is safe to say that the 
mechanisms of CIN in yeast could also be applied to human.  Multicellular organisms may 
respond differently to aneuploidy as compared to yeast.  For instance, whole chromosome 
aneuploidy is largely detrimental in multicellular species (Williams, Prabhu et al. 2008).  
At the cellular level, it has been suggested that the proliferation of aneuploid mouse and 
human cells could be limited through the p53 pathway which do not exist in yeast (Belyi, 
Ak et al. 2010, Thompson and Compton 2010).  Nonetheless, most cancer cells inactivate 
the p53 pathway and could evolve through the production of aneuploidy (Belyi, Ak et al. 
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2010, Navin, Kendall et al. 2011).  Besides aneuploidy, cancer cells also hold mutations 
and epigenetic deregulation.  Yeast will remain a useful experimental model for future 
elucidation of the interplay between small and large genetic changes and their influence on 






















2.9 Figure legends: 
2.9.1 Figure 1: Experimental methods for the generation of aneuploidy in yeast.  
(a) Generation of aneuploidy via triploid meiosis:  A triploid (3N) yeast cell undergoes 
meiosis I with random segregation of homologous chromosomes.  At the end of the first 
meiotic division, two aneuploid progenies are formed. Second meiotic divisions produce 
four highly aneuploid progenies.  
(b) Generation of aneuploidy via conditional centromere:  The endogenous centromere of 
the target chromosome is replaced with a conditional centromere construct PGAL1-CEN3 in 
a haploid yeast cell.  Galactose induces GAL1 promoter activity causing temporary 
inactivation of the centromere; further results in nondisjunction of the target chromosome.  
Following cell division, an aneuploid cell (N+1) containing an extra copy of the target 
chromosome can be obtained.  
(c) Generation of aneuploidy using a karyogamy-defective strain:  A haploid (N) yeast 
strain (kar1Δ15) is crossed with a wild type haploid yeast strain.  Occasionally, a 
chromosome is transferred from one nucleus to the other during abortive mating.  An 
aneuploid (N+1) cell can be selected using selection markers present on each of the 
homologous chromosomes.  (Abbreviations: N, chromosome number). 
 
2.9.2 Figure 2: Characteristic examples of karyotyping methods.  
(a) Karyotypic analysis of five D9-3.3 single colonies of C. albicans followed by southern 
hybridization to a CEN5 probe:  The isochromosome 5 i(5L) hybridized to a CEN5 probe 
is detected in a clone D. Figure is adopted from (Selmecki et al., 2009).  
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(b) Ploidy analysis of a budding yeast aneuploid strain RLY 4938 by FACS:  A 
characteristic shift in G1 peak observed in an aneuploid strain RLY 4938 compared to the 
haploid control indicating an increased DNA content.  
(c) Karyotypic analysis of an aneuploid strain RLY 4938 by a-CGH:  Extra copy of 
chromosomes I, II, VIII, XI and XIII is detected.  Hybridization intensities from all 16 
chromosomes and the mitochondrial genome are plotted as log2 ratios compared to the 
haploid strain. Upper and lower boundaries are truncated at a log2 ratio of +1 and −1, 
respectively.  The location of repetitive elements is indicated at the bottom with vertical 
bars.  Figure is adopted from (Pavelka et al., 2010).  
(d) Karyotypic analysis of an aneuploid strain RLY 4938 by qPCR: An absolute copy 
number of sixteen yeast chromosomes is plotted.  Extra copy of chromosomes I, II, VIII, 
XI and XIII is observed. 
(e) Karyotypic analysis an aneuploid strain RLY 4938 by Next-Generation sequencing: A 































































































































Table 2.10.1: Aneuploidy as an adaptive mechanism under different types of stress in yeast. 
Type of stress Species Aneuploidy 
and implicated 
genes 
Adaptive strategy Reference 
Therapeutic drug:       
Fluconazole (FLC) C. albicans i5: ERG11, 
TAC1  
Resistance is acquired by up-
regulation of ERG11 encoding 
FLC target and TAC1 encoding 
for a regulator of the drug efflux 
system. 
(Selmecki, et al., 
2006, Coste, et al., 






Acquired resistance is attributed 
to up-regulation of ERG11, 
encodes drug target and AFR1, 
encodes major transporter of 
azoles. 
(Sionov, et al., 2010) 
  Disomy IV: 
SEY1, GLO3, 
GCS3 
Up-regulation of genes SEY1, 
GLO3, GCS3 encoding a 
GTPase, linked with 
morphology and integrity of 
endoplasmic reticulum, a site of 
sterol synthesis.  
(Ngamskulrungroj, et 
al., 2012) 
 C. glabrata Chromosome 
M: CDR1 
Elevated drug efflux by up-
regulation of CDR1. 
(Polakova, et al., 
2009) 





Resistance to radicicol is 
acquired by: improved protein 
(Chen, et al., 2012) 
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folding by up-regulation of 
Hsp90 co-chaperone through 
increased expression of STI1. 
Over-expression of PDR5 
improves drug efflux system. 





Improved drug efflux by up-
regulation of ATR1 conferred 
resistance to 4-NQO. 




    





RLM1, MKK2 mediated up-
regulation of genes involved in 
cell wall biogenesis and bud 
neck constriction restoring 
cytokinesis. 
(Rancati, et al., 2008) 
Deletion of  
RPS 24A and  RNR1 




RPS24B and  
RNR3 
It is suggested that gain of 
chromosome IX might have 
been a result of a selection for 
growth advantage by increasing 
gene dosage of the paralogue of 
the deleted gene. 
(Hughes, et al., 2000) 
Nutrient 
Limitations: 
    
Sulphate limitation S. 
cerevisiae 
 Segmental gain 
of  chromosome 
II: SUL1 
Improved drug efflux by up-
regulation of SulP anion 
transporter through elevated 
SUL1 level. 

























C. albicans Monosomy V: 
SOU1 
Monosomy of chromosome 5 
activates SOU1 expression 
enabling l-sorbose. 
(Rustchenko, et al., 
1994, Janbon, et al., 
1998) 




--- (Yona, et al., 2012) 








Aneuploidy as a cause of impaired chromatin silencing and 














The contents are adapted from: 
Aneuploidy as a cause of impaired chromatin silencing and mating-type specification in 
budding yeast. Mulla WA, Seidel CW, Zhu J, Tsai HJ, Smith SE, Singh P, Bradford WD, 






Aneuploidy and epigenetic alterations have long been associated with 
carcinogenesis, but it was unknown whether aneuploidy could disrupt the epigenetic states 
required for cellular differentiation. In this study, we found that ~3% of random aneuploid 
karyotypes in yeast disrupt the stable inheritance of silenced chromatin during cell 
proliferation. Karyotype analysis revealed that this phenotype was significantly correlated 
with gains of chromosomes III and X. Chromosome X disomy alone was sufficient to 
disrupt chromatin silencing and yeast mating-type identity as indicated by a lack of growth 
response to pheromone. The silencing defect was not limited to cryptic mating type loci 
and was associated with broad changes in histone modifications and chromatin localization 
of Sir2 histone deacetylase. The chromatin-silencing defect of disome X can be partially 
recapitulated by an extra copy of several genes on chromosome X. These results suggest 














Studies in unicellular eukaryotes, such as the budding yeast Saccharomyces 
cerevisiae, have provided valuable insights into the effects of aneuploidy on gene 
expression and corresponding cellular phenotypes because diverse aneuploid strains that 
differ only in chromosome stoichiometry, but not in DNA sequence, can be readily 
generated (Pfau and Amon 2012, Mulla, Zhu et al. 2014). In yeast, chromosome copy 
number variation leads to scaled changes in the transcriptome and proteome for most of 
the genes carried on the aneuploid chromosome, as well as expression level changes that 
vary significantly more than the scaled amount for 5-10% of total genes distributed 
throughout the genome (Torres, Sokolsky et al. 2007, Rancati, Pavelka et al. 2008, Pavelka, 
Rancati et al. 2010, Sheltzer, Torres et al. 2012). The widespread but mostly moderate gene 
expression changes caused by aneuploidy lead to quantitative alterations in cell growth 
under a wide range of environmental conditions. However, the existing yeast studies have 
not addressed whether aneuploidy has the potential to alter the stable epigenetic states 
correlated with cellular differentiation. This is in part because yeast cells lack complex 
developmental fates and yeast genome comprises mostly open chromatin accessible to the 
transcriptional machinery (Millar and Grunstein 2006).  
Yeast cells, however, do have a few well-established regions of silenced chromatin, 
including the cryptic mating type loci HML and HMR on chromosome III, the rDNA repeats 
on chromosome XII, and subtelomeric regions (Buhler and Gasser 2009). In particular, 
chromatin silencing at HML and HMR is critical for the specification of the sexual identity 
of yeast, in the form of a or α mating type, which is stably inherited from generation to 
generation. The underlying epigenetic mechanism of mating type specification depends on 
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the recruitment of the Sir2 NAD-dependent histone deacetylase to HM loci through 
interactions with other Sir proteins (Sir1, 3, and 4) and several other accessory factors 
(Liou, Tanny et al. 2005, Kueng, Oppikofer et al. 2013, Behrouzi, Lu et al. 2016). 
Spreading of the Sir protein complex across this region of DNA leads to hypoacetylated 
histones and establishes stably silenced chromatin (Rusche, Kirchmaier et al. 2003). 
In this study, we took advantage of the genetic tools available in yeast and used 
HML silencing as the primary readout to test whether aneuploidy can affect cell identity by 
disrupting heterochromatin chromatin assembly and maintenance. By inducing meiosis in 
triploid cells, we generated thousands of aneuploid colonies and screened them using an 
imaging-based assay to determine the frequency at which aneuploid karyotypes disrupted 
transcriptional silencing at HML. Using a battery of genomic, transcriptomic and cell 
biological analyses, we investigated the mechanisms by which aneuploidy caused defects 
in chromatin silencing and epigenetic inheritance. 
 
3.2 Results 
3.2.1 Diverse aneuploid karyotypes can cause chromatin desilencing 
To investigate whether and at what frequency random chromosome stoichiometries 
could disrupt chromatin silencing, we started with a haploid yeast strain containing a 
yellow fluorescent protein (YFP) with a nuclear localization sequence under the URA3 
promoter, which was inserted into the silent HML locus. This HML::YFP reporter was 
shown previously to respond to transcriptional silencing in a Sir2, and 3-dependent manner, 
like the genes that normally reside at the silent mating type loci (Xu, Zawadzki et al. 2006). 
We converted the haploid strain carrying HML::YFP to a fully isogenic and homozygous 
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triploid strain by cycles of mating-type switching and mating (Figure 1 - figure supplement 
1A) as previously described (Pavelka, Rancati et al. 2010). The resulting triploid strain, 
which exhibited complete silencing at the HML locus as indicated by the lack of YFP 
fluorescence (Figure 1B), were then sporulated and viable meiotic progenies were isolated 
through tetrad dissection. Previous studies showed that ~100% of the resulting colonies 
were aneuploid with random combinations of chromosome numbers, due to the segregation 
of 3 sets of homologous chromosomes during meiosis (Campbell, Doctor et al. 1981, 
Pavelka, Rancati et al. 2010, St Charles, Hamilton et al. 2010). Using fluorescence 
microscopy, we examined and identified individual colonies with defects in the silencing 
of YFP at the HML locus. Roughly 3% (98 out of 3418) of viable aneuploid spore colonies 
exhibited varying degrees of silencing defects. In contrast, we did not observe silencing 
defects in haploid meiotic progenies (n=100) obtained through sporulation of a diploid 
strain carrying the HML::YFP reporter as a control (data not shown).   
To study how the imbalance of specific chromosomes alters chromatin silencing, 
we first determined which of the desilenced aneuploid strains had stable karyotypes, since 
most of the yeast aneuploids obtained through triploid meiosis are karyotypically unstable 
(Pavelka, Rancati et al. 2010). Using fluorescence-activated cell sorting (FACS) and qPCR 
karyotyping analyses, as previously described (Pavelka, Rancati et al. 2010), we identified 
24 aneuploid strains with unique and stable karyotypes, each with gain or loss of multiple 
chromosomes compared to the basal ploidy – defined as the copy number possessed by 
most chromosomes (Table 1). In the desilenced strains, Chromosome (Chr) III, Chr X, Chr 
XII, and Chr XIII showed the most abundant copy number variation (more specifically, 
gain) (Figure 1C). In particular, Chr III and Chr X were significantly enriched as 
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chromosomes in gained aneuploid numbers in the desilenced aneuploid strains compared 
with a set of stable aneuploid strains of the same genetic background (S288c) that were 
isolated through triploid meiosis but not selected for silencing phenotype (Pavelka, Rancati 
et al. 2010) (Figure 1C).  
We subsequently focused on the four aneuploid strains showing the most prominent 
defects in HML silencing for more in-depth analysis (Figure 1B, D). To exclude the 
possibility that the silencing defect was caused by spontaneously arising mutations rather 
than aneuploidy, all four aneuploid strains were subjected to whole-genome sequencing to 
compare with the parental euploid strains. This analysis revealed an absence of coding 
region mutations that were not already present in the parental euploid strains (see Materials 
and Methods).   
Quantification of the mean fluorescence intensity for each of the four aneuploid 
populations showed a significant increase in YFP expression compared with the WT 
haploid control strains (Figure 1D). The extent of HML::YFP reporter desilencing in the 
aneuploid strains was comparable to or greater than that of the ∆sir1 strain (Figure 1D). 
Interestingly, YFP expression was heterogeneous within each aneuploid population, and 
such heterogeneity was also observed in ∆sir1 strain as reported previously (Xu, Zawadzki 
et al. 2006). To ensure the heterogeneous expression pattern of YFP+ and YFP- signals 
within the population was not due to the karyotypic variations, cells with 2x Chr III and 1x 
Chr X gain were sorted into two distinct subpopulations based on YFP fluorescent signal 
for further analysis, and qPCR karyotyping showed that both sub-populations retained the 
expected karyotype with gain of Chr III and X (Figure 1 - figure supplement 1B-D). To 
determine if this heterogeneity was due to the instability of the chromatin silencing state, 
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we performed time-lapse imaging of YFP expression over several cell divisions in 
aneuploid strains. We observed transitions between repression and derepression of the 
HML locus in proliferating cell lineages (Figure 1 - figure supplement 1E-G), which was 
never observed in haploid lineages (data not shown), suggesting that these aneuploid 
karyotypes disrupted the stable inheritance of the silenced chromatin.  
We next used quantitative RT-PCR (qPCR) analysis to confirm the defective HML 
silencing observed by microscopy. This analysis revealed significant derepression of 
several genomic loci across different chromosomes that are normally silenced (Li, Mueller 
et al. 2006, Ellahi, Thurtle et al. 2015), including not only YFP at HML but also the 
subtelomeric genes YFR057W, COS12, AAD15, and PAU4 and the rDNA region gene 
NTS1-2 (Figure 1E). The observation of increased gene expression at all three genomic 
regions previously implicated in chromatin silencing (Talbert and Henikoff 2006) 
demonstrates that aneuploidy can affect global gene expression by altering the state of 
chromatin silencing, in addition to the previously shown effects related directly to changes 
in DNA copy number (Torres, Sokolsky et al. 2007, Rancati, Pavelka et al. 2008, Pavelka, 
Rancati et al. 2010, Sheltzer, Torres et al. 2012).  
 
3.2.2 Chromosome X disomy is the simplest karyotype that disrupts chromatin 
silencing 
Since each of the above strains had multiple aneuploid chromosomes, we 
performed segregation analysis to determine which chromosome aneuploidy was linked to 
the silencing phenotype. We treated two strains, one with gains in Chr III (2x), and X (III, 
III, X-gain) and the other with gains in Chr I, X, XII, and XIII (I, X, XII, XIII-gain), with 
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low concentrations of radicicol, an inhibitor of Hsp90, to induce chromosomal instability 
and karyotype changes (Chen, Bradford et al. 2012). We then isolated and karyotyped 
various aneuploid segregants from these strains (see methods) and analyzed silencing of 
the HML::YFP reporter. Analysis of the aneuploid segregants obtained from the aneuploid 
strain (III, III, X-gain) showed that the desilencing phenotype co-segregated with Chr X as 
the only gained chromosome (referred as disome X hereafter) (Figure 2A). Interestingly, 
the gain of one or two extra copies of Chr III, which carries the HM loci, did not affect 
HML silencing on its own. Furthermore, qPCR analysis revealed that two extra copies of 
Chr III did not cause transcriptional derepression of HML:YFP, subtelomeric genes, or 
rDNA regions (Figure 2B). However, gaining two copies of Chr III did exacerbate the 
silencing defect of disome X (Figure 2A). Disome X segregants independently obtained 
from the second aneuploid strain (I, X, XII, XIII-gain) also showed significant HML 
desilencing (Figure 2A). Conversely, a segregant from the above karyotype with extra 
copies of Chr I, XII, and XIII, but not Chr X, did not show a significant difference in HML 
silencing compared with the haploid control (Figure 2A). These observations establish a 
causal link between Chr X gain and HML desilencing.  
To further test whether an acute gain of Chr X would be sufficient to cause HML 
desilencing, we induced Chr X disomy using a previously described conditional 
centromere strategy (Reid, Sunjevaric et al. 2008, Anders, Kudrna et al. 2009). In both WT 
haploid cells and aneuploid strains with two extra copies of Chr III, we integrated the GAL1 
promoter (Pgal1) into the region of Chr X directly adjacent to the consensus centromere 
sequences (Pgal1-CEN-X). Upon galactose addition, this GAL1 promoter was activated to 
induce mitotic non-disjunction of Chr X, resulting in one viable progeny cell with an extra 
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copy of Chr X and an inviable one per cell division. For both the haploid and aneuploid 
strains that contained the Pgal1-CEN-X construct, growth in galactose resulted in a 
significant increase in YFP expression from HML compared with corresponding control 
strains, Chr X::Pgal1, in which Pgal1 was integrated into Chr X at sites distant from the 
consensus centromere sequences (Figure 2C). This result further confirmed that gain of 
Chr X was sufficient to disrupt chromatin silencing at HML.  
Because the heterogeneity in desilencing was similar between disomy X and Δsir1, 
we further combined disomy X and Δsir1 to test whether these genetic lesions disrupt HML 
silencing through the same or different mechanisms. Notably, the fluorescence of the 
HML::YFP reporter in this double mutant was significantly higher (p < 0.05) than in either 
disome X or ∆sir1 individually, suggesting an additive or synergistic effect between these 
genetic abnormalities on HML locus silencing (Figure 2D). 
 
3.2.3 Disomy X impairs growth arrest in response to α-factor 
MATa haploid yeast cells normally respond to the pheromone α-factor by switching 
from vegetative growth to a G1 cell cycle arrest. Desilencing at HM loci results in the 
expression of both a- and α- specific genes and the inability to respond to pheromones 
(Osborne, Dudoit et al. 2009). To test whether the effect of aneuploidy on silencing 
influences the pheromone-induced growth arrest, we treated WT haploid, Δsir1 and disome 
X strains, all of the a mating type with the endogenous copy of the HML locus (non-YFP 
inserted), with α-factor for 90 min. FACS-based cell cycle analysis showed that, while WT 
haploid cells were fully arrested in the G1 phase, 23%1.7% of Δsir1 and 14%1.5% of 
disome X cells remained in G2 (Figure 3A). We next applied filter discs saturated with α-
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factor to a lawn of WT haploid, Δsir1 and disome X MATa cells. The latter two strains 
showed significant reductions in pheromone sensitivity compared with the WT haploid 
population (Figure 3B). This demonstrates that the silencing defect of disome X impairs 
the ability of these aneuploid cells to undergo growth arrest in response to a paracrine 
factor.  
 
3.2.4 Chromatin desilencing in disome X is associated with increased acetylation of 
H4K16 and reduced Sir2 enrichment across HM loci 
Hypoacetylation of histone H4 at lysine 16 (H4K16) is essential for the 
establishment and maintenance of silencing at HM loci and subtelomeric genes (Katan-
Khaykovich and Struhl 2005, Osborne, Dudoit et al. 2009). The deacetylation of H4K16 is 
carried out by Sir2, an NAD-dependent histone deacetylase that localizes to silenced 
chromatin (Thurtle and Rine 2014). To uncover whether the distribution of acetylated 
H4K16 (H4K16ac) and occupancy of Sir2 is affected in the disome X strain, we performed 
chromatin immunoprecipitation (ChIP) using anti-H4K16ac antibody in the haploid, 
aneuploid, and Δsir1 strains, followed by qPCR using primer sets spanning HML and HMR. 
We observed significantly increased acetylation of H4K16 across both HM loci in disome 
X and Δsir1 cells compared with WT haploid controls (Figure 4A-B). Similarly, we 
performed ChIP using anti-Sir2::HA antibody and found significantly reduced levels of 
Sir2 protein localized to both HM loci in the disome X and Δsir1 strains, compared to WT 
haploid control (Figure 4C-D). These results suggest that the defective silencing of HM 
loci in disome X cells may result from a reduction in chromatin-localized Sir proteins, such 
as Sir2, and the corresponding increased acetylation of H4K16 at these sites.  
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3.2.5 Loss of HML silencing in disome X cells is associated with a dispersed 
distribution of Sir2 and altered chromatin positioning 
The silencing of the HM loci and subtelomeric regions is associated with 
characteristic distributions for both Sir2 protein and the chromatin regions within the 
nucleus (Andrulis, Neiman et al. 1998, Taddei, Van Houwe et al. 2009). To further 
understand the mechanism by which disomy X affects chromatin silencing, we examined 
the localization of endogenous Sir2, tagged at the genomic locus with mTurquoise 
(mTurq), and observed that the Sir2-mTurq signal was more diffuse in disome X compared 
with WT haploid cells (Figure 5A). We quantified this difference by calculating the 
coefficient of variation (CV; standard deviation/mean) of fluorescence pixel intensities 
within the sum projection of each cell (Figure 5B). The CV was significantly reduced for 
Sir2-mTurq fluorescence in disomy X compared with WT haploid populations (p < 0.001, 
two-tailed t-test), particularly in the 35% of aneuploid cells that had a significantly higher 
(p < 0.01) mean expression of YFP from the HML locus than the haploid control. The more 
dispersed Sir2 distribution in disome X cells is consistent with the reduced concentration 
of Sir2 in silenced chromatin regions (Figure 4C-D). This analysis was designed to 
quantitatively reflect the difference in the “sharpness” of Sir2 localization while accounting 
for the difference in overall fluorescence level in each cell (Figure 5 - figure supplement 
1A-C).  
The positioning of chromatin relative to the nuclear envelope is also important for 
silencing (Bystricky, Van Attikum et al. 2009, Mekhail and Moazed 2010). To address 
whether the normal perinuclear positioning of silenced chromatin was disrupted in disome 
X cells, we introduced the LacO array into the HML locus and expressed LacI-GFP to 
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obsereve the LacO array-marked site in the nucleus, demarcated with the nuclear envelope 
(NE) marker Nup60-mCherry. We defined three concentric nuclear zones of equal area - 
NE  (Zone 1), medial (zone 2), and central (zone 3) regions and determined the percentage 
of cells with the GFP puncta, corresponding to HML, in each zone. We observed a 
significant (p < 0.05) reduction in the percentage of disomy X cells with their HML locus 
attached to the NE (zone 1) compared with the WT haploid strain. This was accompanied 
by a corresponding increase in the percentage of cells with HML located in the central 
nuclear zone (zone 3), suggesting that the silencing defect of the disome X strain is 
associated with altered chromatin positioning in the nucleus (Figure 5C).  
 
3.2.6 Gain of Chromosome X alters subtelomeric gene expression through changes in 
H3K4me3 and H3K79me3 
To determine if disomy X leads to a genome-wide alteration of histone 
modification, we assessed two histone modifications associated with active chromatin, 
trimethylation of histone H3 at either Lysine 4 (H3K4me3) or Lysine 79 (H3K79me3), by 
performing chromatin immunoprecipitation followed by next-generation sequencing 
(ChIP-seq). In parallel, we analyzed a portion of the same experimental cultures by RNA 
sequencing (RNA-seq) to correlate genome-wide changes in histone modifications with 
the transcriptional output. The number of methylated genes (~60% of total S. cerevisiae 
genes) in the disome X and WT haploid strains was not significantly different (Table 2). 
Consistent with previous reports (Pokholok, Harbison et al. 2005, Guillemette, Drogaris et 
al. 2011, Takahashi, Schulze et al. 2011), both strains showed an overall positive 
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correlation between gene expression and H3K4me3 enrichment, but not H3K79me3 
(Figure 6 – figure supplement 1A).   
To compare the epigenetic and transcriptional changes in aneuploid cells, we 
plotted the difference in H3K4me3 enrichment between disome X and WT haploid strains 
against the fold change in gene expression for each of the 3502 genes (~57% of the total 
genes in the yeast genome, Table 2) that were expressed with detectable H3K4me3 marks 
in both strains. At the genome-wide level, we found no correlation between an increased 
enrichment of H3K4me3 modifications and increased gene expression in disome X cells 
compared with the haploid control (Figure 6A). Likewise, there was no difference in gene 
expression between disome X and haploid populations for sets of genes that had H3K4me3 
modifications only in one strain or the other (Figure 6 – figure supplement 1B and C). 
However, most of the subtelomeric genes that were expressed and modified in both strains 
(Table 2) were significantly enriched (p-value= 2.5  10-8, Fisher's exact test) for H3K4me3 
modifications and had higher expression levels in disome X cells compared with the 
haploid control (Figure 6A).  
The H3K79me3 histone mark has previously been implicated in the regulation of 
subtelomeric silencing by modulating the binding of Sir proteins to these chromatin 
regions. In our ChIP- and RNA- seq experiments, three subtelomeric genes, COS12, IMD2, 
and YIR042C, showed significantly increased RNA expression levels and enriched 
H3K4me3 and H3K79me3 modifications in disome X cells compared with WT (Figure 
6C-D). Notably, COS12 was previously identified as a target of H3K79me3-regulated 
silencing (Takahashi, Schulze et al. 2011). On the genome-wide level or in subsets of genes 
carrying H3K79me only in one or the other strain, however, we observed no correlation 
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between transcription levels and this epigenetic mark in disome X cells relative to WT 
(Figure 6B, Figure 6 – figure supplement 1D-E and Table 2).  
 
3.2.7 The HML silencing defect results from increased copy number of at least four 
genes on Chr X  
To identify the genetic components that contribute to the silencing defect caused 
by an extra copy of Chr X, we used the HML::YFP reporter and fluorescence microscopy 
to screen the effect of an increased copy number of each of the 304 genes located on Chr 
X, for loss of YFP silencing in the disome III background as a means to sensitize the screen. 
We took advantage of the yeast MOBY library, in which each gene, with its endogenous 
promoter, is carried on a low-copy (centromeric) plasmid (Ho, Magtanong et al. 2009). The 
fifteen Chr X genes with top-ranked silencing defect were further verified by transforming 
the centromeric plasmid into a WT haploid strain (Table 3). Because cells can maintain up 
to four copies of centromeric plasmids, we next integrated a single extra copy of each of 
the top ten candidate genes into a WT haploid genome, but we found that none of these 
individual genes significantly disrupted silencing when present at this level (data not 
shown).  
Two genes, RPL39 and RPS14B, encoding ribosomal proteins, were among those 
with the strongest silencing defects when expressed on a centromeric plasmid. Since 
previous studies showed that overexpression of a ribosomal protein-encoding gene, RPL32, 
impaired silencing (Singer, Kahana et al. 1998), we tested the effect of combining single 
extra copies, via integration, of RPL39 and RPS14B together in the haploid genome; 
however, this combination did not alter silencing of the HML::YFP reporter (Figure 7A, 
44 
 
B). Previous studies also showed that silencing is affected by one other top candidates from 
our MOBY library screen ASF1, which encodes a nucleosome assembly factor (Singer, 
Kahana et al. 1998, Smith, Caputo et al. 1999).  Integration of ASF1 together with DPB11, 
a top hit in our screen but not previously known to affect silencing, into the haploid genome 
also showed no effect on silencing (Figure 7A, B). However, when we combined all four 
genes tested above (RPL39, RPS14B, ASF1, and DPB11) by integrating them into the 
haploid genome, significant HML desilencing was observed compared to the haploid 
control, although the effect was not as strong as that in disome X cells (Figure 7A, B). 
These results suggest that the disomy X-induced desilencing is complex and requires the 
combined effects of at least four Chr X-linked genes. 
 
3.4 Summary: 
Our imaging-based analysis of thousands of freshly-produced aneuploid yeast 
colonies demonstrated that roughly 3% of random aneuploid karyotypes disrupt 
transcriptional silencing at the HML locus, indicating that aneuploidy can impact gene 
expression to an extent far greater than the effects resulting from direct gene-dosage 
changes. We identified specific karyotypic features associated with the silencing defect, 
with the simplest being gain of Chr X, which is sufficient to destabilize the epigenetic state 
and alter cellular responses to a relevant physiological factor (-factor). Furthermore, the 
loss of silencing at the HM loci on Chr III and transcriptional derepression at subtelomeric 
regions on different chromosomes induced by Chr X disomy correlated with changes in 
the histone modification landscape, including increased H4K16 acetylation, and H3K4 and 
H3K79 trimethylation. Moreover, the silencing defect of disome X cells was associated 
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with perturbed chromatin localization within the nucleus. The genetic basis of disome X-
induced desilencing is complex, requiring at least four Chr X genes. Taken together, our 























3.4 Main Figure legends 
Figure 3.4.1: Aneuploid yeast strains show defective silencing at HML, subtelomeric, 
and rDNA chromatin regions. 
(A) The design of a microscopy-based screen to isolate karyotypically stable aneuploid 
strains, generated by inducing triploid meiosis, that exhibit defective silencing of the HML 
locus. 
(B) Representative fluorescence images show HML::YFP reporter expression in euploid 
and aneuploid cells of various karyotypes, as indicated. YFP expression from the HML 
locus is not detectable in the parental haploid, diploid and triploid strains; YFP fluorescence 
is heterogeneous within Δsir1 and aneuploid cell populations suggests defective silencing 
at the HML locus. Scale bar, 4 µm. 
(C) The bar plot shows the number of times each of the sixteen yeast chromosomes was 
found to be aneuploid (chromosome number different from the basal ploidy) in 24 strains 
with defective silencing. Aneuploidies of Chr III and Chr X are significantly 
overrepresented in strains with defective silencing compared with other 38 stable aneuploids 
isolated by the same method (Pavelka, Rancati et al. 2010). *p < 0.05 for Chr III and Chr 
X; p = 0.09 for Chr XII calculated using an exact binomial test. 
(D) The box plot shows mean YFP intensities, determined by microscopy as in Figure 1B, 
for 175 individual cells per strain. The karyotype of each aneuploid strain is indicated; WT 
and Δsir1 cells are haploid. The box spans the first through third quartile values, the line 
inside each box indicates the median, the solid black square designates the mean, and the 
whiskers mark the 90/10 percentile range. *p < 0.01, **p < 0.001, ***p < 0.0001 compared 
with WT haploid; calculated using a Mann–Whitney U test. 
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(E) The bar plot depicts the expression, measured by quantitative RT-PCR, of several 
normally silenced genes: YFP inserted into the endogenous HML locus; subtelomeric genes 
YFR057W (Chr III), COS12 (Chr XII), AAD15 (Chr XV), and PAU4 (Chr XII); and rDNA 
gene NTS1-2 (Chr XII). Transcriptional levels are plotted as fold expression relative to the 
WT haploid strain. Error bars represent the standard deviation (SD) of three biological 
replicates. *p < 0.05, **p < 0.01, ***p < 0.005 compared with WT haploid; calculated using 
a two-tailed t-test. 
 
Figure 3.4.2: Gain of Chr X is sufficient to disrupt silencing. 
(A) The box plot shows mean YFP intensities, determined by microscopy of 125 individual 
cells for each of the following strains: WT haploid, Δsir1, and two parental aneuploid strains 
(Gain of III, III, X and Gain of I, X, XII, XIII) and their segregants (Gain of III; Gain of III, 
III; and Gain of I, XII, XIII). The box spans the first through third quartile values, the line 
inside each box indicates the median, the solid black square designates the mean, and the 
whiskers mark the 90/10 percentile range. *p < 0.01, **p < 0.001, ***p < 0.0001 compared 
with WT haploid unless indicated by brackets; calculated using a Mann–Whitney U test. 
(B) The bar plot depicts the expression, measured by quantitative RT-PCR, of several 
normally silenced genes in haploid and aneuploid cells with two extra copies of Chr III. These 
genes are YFP inserted into the endogenous HML locus; subtelomeric genes YFR057W (Chr 
III), COS12 (Chr XII), AAD15 (Chr XV), and PAU4 (Chr XII); and rDNA gene NTS1-2 
(Chr XII). Transcription levels are plotted as fold expression relative to the WT haploid 
strain and not significantly different in Gain III, III strain compared to WT haploid (p < 




 (C) The box plots show mean YFP intensities, determined by microscopy of 125 individual 
cells for each of the indicated WT haploid or aneuploid strains. The GAL1 promoter (Pgal1) 
was integrated into Chr X either directly adjacent to (Pgal1-CEN-X) or far from (Chr 
X::Pgal1) consensus centromere sequences. The box plot presentation and statistical 
analysis are performed as described in Figure 2A.  
 (D) The box plots show mean YFP intensities, determined by microscopy of 125 individual 
cells for each of the following strains: WT haploid, Δsir1, disome X/SIR1 and disome 
X/Δsir1 double mutant. The box plot presentation and statistical analysis are performed as 
described in Figure 2A. 
 
Figure 3.4.3: Cells with a gain of Chromosome X show abnormal growth arrest in 
response to α-factor. 
(A) The plots show FACS-based DNA content analysis, indicating cell cycle stage, in 
MATa WT haploid, Δsir1, and disome X strains. Left panels represent untreated cells; right 
panels represent strains treated with 2 µg/ml α-factor for 90 min. Peaks overlapping with 
the red dotted line represent cells in the G1 phase with a haploid genome content (1N). 
Peaks overlapping with the blue dotted line represent cells in the G2 phase with a diploid 
genome content (2N). Percentages are the fraction of total cells in G2, ± SD. *p < 0.001 
compared with WT haploid; calculated using a two-tailed t-test. 
(B) Images depict a pheromone sensitivity assay conducted by applying filter discs carrying 
α-factor (15 µl of 2 µg/ml) to lawns of WT haploid, Δsir1, or disome X MATa strains. The 
images shown were used to calculate the size of the zone devoid of cell growth (the region 
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between the rim of the disc and the dashed circle); these areas, indicative of cellular 
sensitivity to α-factor, were normalized to the WT haploid strain and plotted. The plot 
shows the mean and SD from three replicates per strain. *p < 0.001 compared with WT 
haploid; calculated using a two-tailed t-test. 
 
Figure 3.4.4: HM desilencing in disome X cells correlates with increased H4K16 
acetylation and reduced Sir2 enrichment across HM loci. 
(A-B) Bottom: The plots show levels of H4K16 acetylation across the HML (A) and HMR 
(B) loci in disome X and Δsir1 strains relative to WT haploid cells, determined using anti-
H4K16ac chromatin immunoprecipitation (ChIP) followed by quantitative RT-PCR 
(qPCR) analysis. Top: Schematics of the HM loci indicate the genomic positioning of 
primer sets A to F used for qPCR. Plots show the mean and SD from three biological 
replicates. *p < 0.05, **p < 0.01, ***p < 0.005 calculated using two-tailed t-test and indicate 
statistically significant difference in H4K16 acetylation level at corresponding genomic 
locations in Δsir1 and disome X strains compared to WT haploid.  
(C-D) The plots indicate Sir2 occupancy across the HML (C) and HMR (D) loci in disome 
X and Δsir1 strains relative to WT haploid cells, determined using anti-Sir2::HA ChIP 
followed by qPCR analysis with the same primer sets depicted in (A) and (B) for (C) and 
(D), respectively. Plots show the mean and SD from three biological replicates. *p < 0.01, 
**p < 0.005 compared with WT haploid; calculated using t-test and indicate a statistically 
significant difference in Sir2 occupancy at corresponding genomic locations across HM 




Figure 3.4.5: Disome X cells display abnormal Sir2 protein localizations and lack proper 
perinuclear positioning of silenced chromatin region. 
(A) Representative fluorescent images are shown for Sir2-mTurq and the HML::YFP 
reporter in WT haploid and disome X strains. White boxes in the top panels display 
magnified images (insets) of representative Sir2 foci. Scale bar, 4 µm. 
(B) The scatter plots show, for each WT haploid or disome X cell, the coefficient of variation 
(CV) of Sir2-mTurq fluorescence plotted against the mean YFP pixel intensity. The CV 
was calculated as the ratio of the standard deviation to the mean pixel intensity of Sir2-
mTurq fluorescence over the total area of the sum projection of each cell. The CV in the 
disome X strain is significantly reduced compared with haploid cells (p < 0.001, one-tailed 
t-test), indicating a more diffusive distribution of Sir2 in aneuploid cells. Additionally, 35% 
of disome X cells (determined using Tukey's outlier test on the WT strain) have 
significantly higher (p < 0.01) mean YFP intensities than the WT haploid cell population; 
these disome X cells also show significantly (p < 0.05) reduced CV compared with haploid 
controls. 
(C) Left: Representative images show the position of the HML locus, tagged with LacO 
arrays and bound by LacI-GFP, relative to the nuclear envelope (NE), marked by Nup60-
mCherry. Top right: The illustration shows the three concentric zones of the equal area used 
to map the location of the HML locus. Bottom right: The bar graph shows the percentage of 
WT haploid or disome X cells with GFP puncta located in each of the three zones (n = 100 
cells per strain). Confidence values (p) are shown for a χ2 analysis comparing random (33% 
in each zone) and test distributions. *: Value significantly differs from a random distribution 
(p < 0.005, Chi-square test for independence). Scale bar, 1 µm. 
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Figure 3.4.6: Genome-wide analysis shows that disome X cells upregulate histone 
modifications and transcription of typically silenced genes. 
(A-B) Gene expression changes determined by RNA-seq are plotted on the X-axis as log2 
fold change (disome X/WT haploid), and H3K4me3 (A) and H3K79me3 (B) histone 
modification enrichments determined by ChIP-seq are plotted on the Y-axis as the difference 
in Z-scores (disome X - WT haploid), with each dot representing an individual gene. Genes 
that were expressed (RPKM > 1) and enriched for a given histone modification in both 
haploid and disome X strains were included in this analysis and categorized into four 
groups: (I) Genome-wide, representing all of the included genes (grey dots); (II and III) 
Subsets of genes from category I that were significantly (1.5- fold change, p < 0.01) 
upregulated (blue dots) or down-regulated (green dots) in disome X cells compared with 
haploid controls; and (IV) subtelomeric genes (red dots). Note that identities of 
subtelomeric genes in A and B are different because the genes with occupancy of the two 
histone markers (K4me and K79me) were not the same and hence are at different points 
along the x-axis of A and B. More detailed information about the genes in these categories 
is listed in Table 2. 
(C) Transcriptional levels of COS12 (Chr XII), IMD2 (Chr VIII), and YIR042C (Chr IX) 
genes were measured by RNA-seq and plotted as fold change (disome X/WT haploid). Each 
bar depicts the mean and SD of three biological replicates. *p < 0.001 compared with WT 
haploid; calculated using two-tailed t-test. 
(D) Enrichment profiles of H3K4me3 and H3K79me3 were determined by ChIP-seq and 
plotted as reads per million per nucleotide (RPM) for the indicated gene ORFs (black 
arrows), with 500 bp of flanking sequence on both sides. Each plot shows the enrichment 
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profiles for two biological replicates per WT haploid or disome X strain. Both epigenetic 
marks are enriched at all three genomic loci in disome X cells compared with the haploid 
controls. 
 
Figure 3.4.7: The combined increase in copy number of at least four genes on Chr X 
causes HML silencing defects. 
(A) Representative images of YFP fluorescence from the HML::YFP reporter in Δsir1, 
disome X, and WT haploid cells with a single extra copy of the indicated genes, where 
relevant. Scale bar, 4 µm.  
(B) The box plot shows the mean YFP intensity of 125 cells for each strain shown in Fig. 
7A. The box spans the first through third quartile values, the line inside each box indicates 
the median, the solid black square designates the mean, and the whiskers mark the 90/10 
percentile range. *p < 0.01, **p < 0.001, ***p < 0.0001 compared with WT haploid; 












3.5 Supplementary Figure legends 
Figure 3.5.1 – figure supplement 1.  
(A) A schematic representation of the genetic manipulations used to generate isogenic 
diploid and triploid strains from the parental WT haploid strain, which has nuclear 
localization sequence-tagged YFP inserted into the HML locus. 
(B) FACS sorting of YFP- vs YFP+ cells from the strain with 2x Chr III and 1x Chr X gain. 
Red and yellow line outlines the population of YFP- and YFP+ cells sorted for the qPCR 
analysis in C and D, respectively. 
(C-D) qPCR karyotyping of YFP- (C) and YFP+ (D) cell population sorted from the strain 
with 2x Chr III and 1x Chr X gain. Chromosome copy numbers of sixteen yeast 
chromosomes are plotted as mean and SD of three technical replicates.  
 (E-G) Confocal images of YFP fluorescence, taken at the indicated time points during 
time-lapse imaging, show transitions between repression and derepression of the HML 
locus in proliferating lineages of aneuploid yeast cells with the following karyotypes: (E) 
Gain of III, III, X; (F) Loss of I, V, VII, VIII, XI (basal ploidy, 2N); and (G) Gain of I, X, 
XII, XIII. Arrows point to mother cells that switched from the silenced to the desilenced 
state. The circle outlines the boundary of the cell.  Scale bar, 4 µm.  
 
Figure 3.5.5 – figure supplement 1.  
(A-B) Western blot analysis of total Sir2 protein by using anti-Sir2 and anti--PGK 
(loading control) antibodies for the following strains: WT haploid, Δsir1, disome X, and 
Δsir2/SIR2.  The total Sir2 protein levels were quantified using densitometric analysis, 
normalized to the WT haploid strain and plotted in (B).  
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(C) The box plot shows mean Sir2-mTurq intensities, determined by microscopy of 68 
individual cells for WT haploid and disome X strains. The box spans the first through third 
quartile values, the line inside each box indicates the median, the solid black square 
designates the mean, and the whiskers mark the 90/10 percentile range. *p < 0.001 
compared with WT haploid; calculated using a Mann–Whitney U test. 
(D) The box plots show mean YFP intensities, determined by microscopy of 100 individual 
cells for each of the following strains: WT haploid, Δsir1, disome X and Δsir2/SIR2, all with 
YFP inserted into HML. The box plot presentation and statistical analysis are performed as 
described in (C); *p < 0.01, **p < 0.001. 
Figure 3.5.6 – figure supplement 1.  
(A) Expression levels determined by RNA-seq experiments are plotted as log10 of the 
RPKM values on the X-axis, and H3K4me3 enrichment determined by ChIP-seq analysis is 
plotted as log10 of the Z-scores on the Y-axis for individual genes in disome X (red) and 
WT haploid (green) strains.  
(B-E) The violin plots show gene expression levels, plotted as log2 of the RPKM values, in 
disome X and WT haploid strains for individual genes carrying: (B) H3K4me3 enrichment 
in WT haploid but not disome X cells; (C) H3K4me3 enrichment in disome X but not 
haploid cells; (D) H3K79me3 enrichment in haploid but not disome X cells; and (E) 
H3K79me3 enrichment in disome X but not haploid cells. In these plots, the width of the 
violin shape at a given log2(RPKM) value indicates the number of genes expressed at that 
level. The white dot represents the geometric mean RPKM value for all the genes, and the 
thick and thin lines are box plots that show the first and third quartiles and 1.5 times 
interquartile ranges (IQR), respectively. 
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3.6 Table Legends 
Table 3.6.1: The karyotypes of stable aneuploid strains that exhibit defective silencing of 
YFP at the HML locus obtained from a microscopy-based screen are listed. 
 
Table 3.6.2: The number of genes plotted for each category in Figure 6A-B and Figure 6 
– figure supplement 1 is listed. 
 
Table 3.6.3: A list of fifteen Chr X genes that cause the strongest silencing defects as a 
result of increased copy number. Genes leading to the loss of HML::YFP silencing when 
copy number is increased are listed with a functional description and a desilencing score. The 
desilencing score was calculated as the average YFP intensity in WT haploid strains 
carrying individual candidate genes on a low-copy (centromeric) plasmid, relative to the 
average YFP fluorescence in the disome X strain. Average YFP intensities were calculated 
using 3 biological replicates per strain. 
 
Table 3.6.4. List of yeast strains used in this study, and not listed in table 1. 
 








3.7 Main Figures 
































































































































































































































































































































































































































































































































































































































































































































































































































































3.8 Supplementary Figures 






























































































































































































































































































































































3.9 Tables  
3.9.1 Table 1: List of stable aneuploid karyotypes exhibiting defective silencing of the 



















RLY9071 2N 1 2 2 2 1 2 1 1 2 2 1 2 2 2 2 2 
RLY9072 2N 2 2 3 2 2 2 2 2 2 2 2 2 3 2 2 2 
RLY9073 2N 3 2 2 2 2 2 2 2 2 3 2 3 2 2 2 2 
RLY9074 2N 2 2 2 2 2 2 2 2 3 2 2 2 2 2 2 3 
RLY9075 1N 1 2 1 1 1 1 1 1 1 1 1 1 2 1 1 1 
RLY9076 1N 1 1 3 1 1 1 1 1 1 2 1 1 1 1 1 1 
RLY9077 1N 2 1 1 1 1 1 1 1 1 2 1 2 2 1 1 1 
RLY9078 1N 1 1 2 1 2 1 1 1 1 1 1 2 1 1 1 1 
RLY9079 1N 1 1 1 1 1 1 1 2 2 2 1 1 2 2 1 1 
RLY9080 1N 1 1 1 1 1 1 1 1 2 1 1 1 2 1 2 1 
RLY9081 1N 1 1 1 1 1 1 1 1 1 2 1 2 2 1 1 1 
RLY9082 1N 1 1 2 1 1 1 1 1 1 1 1 2 1 1 1 1 
RLY9083 1N 1 1 2 1 1 1 1 1 2 1 1 1 2 1 1 1 
RLY9084 1N 1 2 1 1 1 1 1 1 1 1 1 2 1 1 1 1 
RLY9085 1N 1 1 2 1 1 1 1 1 1 2 1 1 1 1 1 2 
RLY9086 1N 1 1 2 1 1 1 1 2 1 1 1 1 1 1 1 2 
RLY9087 1N 1 1 1 1 1 1 1 1 2 1 1 1 1 1 2 2 
RLY9088 1N 2 2 1 1 1 1 1 1 1 2 1 2 1 1 1 1 
RLY9089 1N 1 2 1 1 1 1 1 1 1 1 1 1 2 1 1 2 
RLY9090 1N 1 1 2 1 1 1 1 1 1 1 2 2 1 1 1 1 
RLY9091 1N 1 1 1 1 1 1 1 2 1 2 1 1 1 1 1 1 
RLY9092 1N 2 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 
RLY9093 1N 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 2 







3.9.2 Table 2: The number of genes plotted for each category in Figure 6A-B and Figure 













disome X  
Category IV: 
Subtelomeric (out of 220 
genes located in 15kb 
region at both ends of 
chromosomes) 
Number of genes 
with H3K4me3 score 
present in both 
disome X and WT 
3502 24 24 18 
Number of genes 
with H3K4me3 score 
present in disome X 
but not in WT 
197 0 11 6 
Number of genes 
with H3K4me3 score 
present in WT but not 
in disome X 
289 3 6 3 
Number of genes 
without H3K4me3 
score but expressed 
in both disome X and 
WT  
2196 65 121 75 













disome X  
Category IV: 
Subtelomeric (out of 220 
genes located in 15kb 
region at both ends of 
chromosomes) 
Number of genes 
with H3K79me3 
score present in both 
disome X and WT 
2249 6 6 6 
Number of genes 
with H3K79me3 
score present in 
disome X but not in 
WT 
364 2 2 4 
Number of genes 
with H3K79me3 
score present in WT 
but not in disome X 
255 4 1 1 
Number of genes 
without H3K79me3 
score but expressed 
in both disome X and 
WT   
3316 80 153 91 
Total 6184 92 162 102 
68 
 




to disome X 
Description of gene  
Disome X 1 -- 
WT+SRS2 0.568966 DNA helicase and DNA-dependent ATPase; involved in DNA repair and 
checkpoint recovery, affects genome stability; functional homolog of 
human RTEL1. 
WT+DPB11 0.53 DNA replication initiation protein; loads DNA pol epsilon onto pre-
replication complexes at origins; ortholog of human TopBP1. 
WT+RPL39 0.489655 Ribosomal 60S subunit protein L39; required for ribosome biogenesis; loss 
of both Rpl31p and Rpl39p confers lethality; homologous to mammalian 
ribosomal protein L39. 




0.481724 Protein component of the small (40S) ribosomal subunit; required for 
ribosome assembly and 20S pre-rRNA processing; homologous to 
mammalian ribosomal protein S14 and bacterial S11. 
WT+PRE3 0.422759 Beta 1 subunit of the 20S proteasome; responsible for cleavage after acidic 
residues in peptides. 
WT+SPT10 0.387069 Histone H3 acetylase with a role in transcriptional regulation; involved in S 
phase-specific acetylation of H3K56 at histone promoters, which is 
required for recruitment of SWI/SNF nucleosome remodeling complex. 
WT+CYR1 0.358621 Adenylate cyclase; the cAMP pathway controls a variety of cellular 
processes, including metabolism, cell cycle, stress response, stationary 
phase, and sporulation. 
WT+HIR3 0.331552 Subunit of the HIR complex; a nucleosome assembly complex involved in 
regulation of histone gene transcription; involved in position-dependent 




0.31569 Cullin subunit of a Roc1p-dependent E3 ubiquitin ligase complex; role in 
anaphase progression; required for recovery after DSB repair. 
WT+RPA34 0.295 RNA polymerase I subunit A34.5; essential for nucleolar assembly and for 
high polymerase loading rate; nucleolar localization depends on Rpa49p. 
WT+SWI3 0.291552 Subunit of the SWI/SNF chromatin remodeling complex; SWI/SNF 
regulates transcription by remodeling chromosomes. 
WT+MIR1 0.269138 Mitochondrial phosphate carrier; imports inorganic phosphate into 
mitochondria. 
WT+VPS25 0.268103 Component of the ESCRT-II complex; ESCRT-II is involved in ubiquitin-
dependent sorting of proteins into the endosome. 
WT+NUP85 0.254483 Subunit of the Nup84p subcomplex of the nuclear pore complex (NPC); 
plays roles in several processes that may require localization of genes or 
chromosomes at the nuclear periphery, and chromatin silencing; 




3.9.4 Table 4: List of yeast strains used in this study, and not listed in table 1.  
Name Genotype Experiment 
RLY9017 MATα; ura3; his3; trp1; leu2; hml::PURA3-NLS-YFP  Fig 1B, 1D, 1E, Fig 1-S1A; Fig 
2A, 2B, 2D; Fig 5-S1A,B,D; Fig 
6A-D; Fig 6-S1, Fig 6-Sup table 
1  
RLY9018 MATa; ura3; his3; trp1; leu2; hml::PURA3-NLS-YFP Fig 1-S1A 
RLY9019 MATa/α; RLY9017 × RLY9017 Fig 1-S1A 
RLY9020 MATa/a; (derived from RLY9019 by mating type 
switching) 
Fig 1-S1A 
RLY9021 MATa/a/α; RLY9020 × RLY9017   Fig 1-S1A 
RLY9022 RLY9017; sir1∆::KanMX6  Fig 1B, 1D; Fig 2A, 2D,  
RLY9023* ura3; his3; trp1; leu2; hml::PURA3-NLS-YFP/hml::PURA3-
NLS-YFP; + Chr III 
Fig 2A 
RLY9024* ura3; his3; trp1; leu2; hml::PURA3-NLS-YFP/hml::PURA3-
NLS-YFP/hml::PURA3-NLS-YFP; + Chr III; + Chr III 
(haploid strain with two extra copies of Chr III) 
Fig 2A, 2B 
RLY9025 MATa; ura3; his3; trp1; leu2; hml::PURA3-NLS-YFP; + 
Chr X (derived from RLY9076) 
Fig 2A, 2C, 2D, Fig 6A-D, Fig 6-
S1A-E, Fig 6-Sup table 1   
RLY9026 MATa; ura3; his3; trp1; leu2; hml::PURA3-NLS-YFP; + 
Chr X (derived from RLY9077) 
Fig 2A 
RLY9027* ura3; his3; trp1; leu2; hml::PURA3-NLS-YFP; + Chr I; + 
Chr XII; + Chr XIII (derived from RLY9077) 
Fig 2A 
RLY9028 RLY9017; Chr X::Pgal1-URAKL-Chr X Fig 2C 
RLY9029 RLY9017;  Chr X::Pgal1-URAKL-CenX Fig 2C 
RLY9030 RLY9024;  Chr X::Pgal1-URAKL-Chr X Fig 2C 
RLY9031 RLY9024;  Chr X::Pgal1-URAKL-CenX Fig 2C 
RLY9032 RLY9025; sir1∆::KanMX6;  Fig 2D 
RLY9033 MATa; ura3; his3; trp1; leu2;  Fig 3A-B 
RLY9034 MATa; ura3; his3; trp1; leu2; sir1∆:: KanMX6 Fig 3A-B 
RLY9035 MATa; ura3; his3; trp1; leu2; + Chr X  Fig 3A-B 
RLY9036 RLY9017; SIR2::HA-HIS3 Fig 4A-D 
RLY9037 RLY9022; SIR2::HA-HIS3 Fig 4A-D 
RLY9038 RLY9026; SIR2::HA-HIS3 Fig 4A-D 
RLY9039 RLY9017; SIR2::mTurq-KanMX6 Fig 5A-B, Fig 5-S1C 
RLY9040 RLY9025; SIR2::mTurq-KanMX6; + Chr X Fig 5A-B, Fig 5-S1C 
RLY9041 RLY9033; hmlprox::lacO(256)-LEU2; HIS3::PURA3-
LacI::GFP-KanMX; NUP60::mCherry-URA3 
Fig 5C 
RLY9042 RLY9035; hmlprox::lacO(256)-LEU2; HIS3::PURA3-







RLY9043 RLY9017; + URA3 (Integration of NcoI digested pRS306, 
URA3) 
Fig 7A-B 
RLY9044 RLY9022; + URA3 (Integration of NcoI digested pRS306, 
URA3) 
Fig 7A-B 
RLY9045 RLY9025; + URA3 (Integration of NcoI digested pRS306, 
URA3) 
Fig 7A-B 
RLY9046 RLY9017; + ASF1 + DPB11 (Integration of NcoI digested 
pWM1 into URA3 locus)  
Fig 7A-B 
RLY9047 RLY9018; + RPL39 + RPS14B (Integration of HpaI 
digested pWM2 into DPB11 locus)  
Fig 7A-B 
RLY9048* ura3; his3; trp1; leu2; hml::PURA3-NLS-YFP; + RPL39 + 
RPS14B + ASF1 + DPB11  
Fig 7A-B 
RLY9049 RLY9025; + Chr X; + Moby plasmid without ORF, CEN-
ARS, URA3 
Fig 7-Sup table 1 
RLY9050 RLY9017; + PRE3 (YJL001W, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9051 RLY9017; + CYR1 (YJL005W, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9052 RLY9017; + RTT101 (YJL047C, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9053 RLY9017; + DPB11 (YJL090C, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9054 RLY9017; + SRS2 (YJL092W, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9055 RLY9017; + ASF1 (YJL115W, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9056 RLY9017; + SPT10 (YJL127C, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9057 RLY9017; + RPA34 (YJL148W, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9058 RLY9017; + SWI3 (YJL176C, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9059 RLY9017; + RPL39 (YJL189W, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9060 RLY9017; + RPS14B (YJL191W, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9061 RLY9017; + NUP85 (YJR042W, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9062 RLY9017; + MIR1 (YJR077C, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9063 RLY9017; + VPS25 (YJR102C, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9064 RLY9017; + HIR3 (YJR140C, MOBY-ORF, CEN-ARS, 
URA3) 
Fig 7-Sup table 1 
RLY9065 RLY9019; sir2∆::KanMX6/SIR2 Fig 5-S1A,B,D 
   
* matying type unknown 
 




3.9.5 Table 5: List of plasmids used in this study. 
    
Name  RLB No. Description  Source 
pWM1  RLB912 pRS306, RPL39, RPS14B This study 
pWM2 RLB913 pRS306, ASF1, DPB11 This study 
pWM3 RLB884 KAN, URA3, CEN-ARS, (MOBY plasmid without ORF)  Li Lab 


























Some contents in this chapter are adapted from:   
 
Aneuploidy as a cause of impaired chromatin silencing and mating-type specification in 
budding yeast. Mulla WA, Seidel CW, Zhu J, Tsai HJ, Smith SE, Singh P, Bradford WD, 








4.1 Loss of chromatin silencing is associated with specific karyotypic features 
Our unbiased approach to identify chromosome stoichiometries associated with 
disrupted chromatin silencing revealed that Chr III and Chr X were frequently gained in 
cells lacking stable silencing at the HML locus. Notably, this pattern of chromosome 
enrichment was significantly different from that found in viable, karyotypically-stable 
aneuploid strains obtained through triploid meiosis (Pavelka, Rancati et al. 2010), 
suggesting that chromatin desilencing is not an obligatory outcome of abnormal 
chromosome numbers, but rather, is caused by specific chromosome imbalance. We 
expected that Chr III and Chr XII would be enriched in our screen since extra copies of 
these chromosomes would increase the copy number of heterochromatic DNA, which 
could potentially titrate silencing factors (Smith, Brachmann et al. 1998, Michel, 
Kornmann et al. 2005, Dodson and Rine 2015). However, only chromosome III gain was 
enriched and contributes to desilencing, but it was insufficient on its own for significant 
desilencing. Chr X, by contrast, lacks any known regions of silenced chromatin other than 
the subtelomeric DNA, and so the effect of extra copies of this chromosome was unlikely 
to be related to the titration of silencing factors. Our functional analysis suggests that the 
mechanisms underlying disome X-associated desilencing are complex (discussed further 
below).   
It is important to point out that the aneuploid karyotypes that we identified did not 
appear to lead to a single state of chromatin silencing or desilencing but instead resulted in 
heterogeneous populations of cells with respect to gene expression from the normally 
silenced chromatin regions.  Although the different levels of YFP expression in individual 
YFP+ cells might be due to the natural gene expression noise, the co-existence of 
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considerable fractions of both YFP+ and YFP- cells in each of the aneuploid populations 
suggests that these karyotypes lead to instability of the epigenetic state that is stably 
inherited in normal haploid cells. 
 
4.2 The impact of Chr X disomy on histone modifications at silenced and non-silenced 
loci 
H3K4 trimethylation is considered to be a mark of active transcription, given that 
its occupancy is generally high at the promoters of actively transcribed genes (Pokholok, 
Harbison et al. 2005, Guillemette, Drogaris et al. 2011). Supporting this notion, our studies 
show a positive correlation between enrichment of this histone mark and transcriptional 
activity in both haploid and aneuploid strains. In yeast, H3K4 trimethylation is carried out 
by the Set1 complex and transcriptional outcomes related to changes in this mark are 
partially dependent on the location of genes in active or silent chromatin regions (Bryk, 
Briggs et al. 2002, Krogan, Dover et al. 2002, Santos-Rosa, Schneider et al. 2002). 
Although H3K4 is generally hypermethylated within regions of euchromatin and 
hypomethylated within heterochromatin, loss of H3K4me3 due to deletion of SET1 had 
little effect on coding gene expression (Margaritis, Oreal et al. 2012). Consistently, our 
transcriptome analysis in disome X strains does not show a correlation between H3K4me3 
and global transcriptional activation. However, in the case of silent domains, such as 
subtelomeric genes, we indeed found that both H3K4me3 modifications and gene 
expression were increased in disome X cells compared with the haploid control strain. The 
significant changes in histone modification patterns, combined with transcriptional 
derepression at many loci in regions of silent chromatin (mating-type loci, rDNA, and 
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subtelomeric DNA) in disome X demonstrated that aneuploidy has the capacity to alter the 
histone-modification profile. It should be noted, however, that RNA-seq data showed that 
most of the subtelomeric genes are not strongly affected by Chr X disomy, suggesting that 
this aneuploidy does not have a general effect on silencing at subtelomeres. However, this 
is consistent with the previous observation that expression of subtelomeric genes in S. 
cerevisiae is largely uninfluenced by mutations in Sir proteins and Sir-based silencing is 
not a widespread phenomenon at telomeres despite strong enrichment of Sir proteins at 
telomeric regions (Takahashi, Schulze et al. 2011, Ellahi, Thurtle et al. 2015). 
 
4.3 Potential mechanisms by which Chr X disomy disrupts stable epigenetic 
inheritance 
We investigated several non-mutually exclusive mechanisms by which gain of Chr 
X could disrupt stable chromatin silencing. First, the defect in silencing could be due to a 
moderately reduced Sir2 level in Disome X compared to haploid (Figure 5 - figure 
supplement 1A-C). However, this is unlikely because previous study (Dodson and Rine 
2015) and our own experiments showed that SIR2 is not haploinsufficient for silencing: 
heterozygous SIR2 diploid strain (sir2/SIR2), in which Sir2 level was reduced by an 
extent similar to that in disome X, did not compromise HML silencing (Figure 5 - figure 
supplement 1D). Second, we explored the possibility that NAD biosynthesis could be 
compromised because three genes (BNA1, BNA2, BNA4) involved in this pathway are 
located on Chr X, and low NAD levels have been linked to defective silencing phenotypes 
(Grozinger, Chao et al. 2001, Sandmeier, Celic et al. 2002, Bedalov, Hirao et al. 2003). 
However, supplementing disome X strains with NAD did not rescue the desilencing 
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phenotype (data not shown). Third, our comprehensive screen for Chr X genes showed that 
a combination of four genes partially recapitulated the desilencing phenotype of disome X 
when each is increased by only a single copy. The known functions of these four genes are 
diverse, ranging from ribosomal components to a histone chaperone and a DNA 
polymerase subunit, suggesting that chromatin desilencing in disome X results from the 
combinatorial effects of multiple pathways that may each contribute to the establishment 
of the silenced chromatin. This is consistent with previous studies showing that aneuploidy 
confers complex or significant phenotypic changes by multigenic mechanisms (Selmecki, 
Forche et al. 2006, Rancati, Pavelka et al. 2008, Selmecki, Gerami-Nejad et al. 2008, 
Pavelka, Rancati et al. 2010, Chen, Bradford et al. 2012, Chen, Mulla et al. 2015).  
 Another possible mechanism by which aneuploidy could impact silencing is by 
affecting the defined chromosome organization within the nucleus, whereby 
heterochromatin-like regions are tethered to the nuclear periphery and form a specialized 
structural compartment, which is required for Sir proteins to establish silencing (Andrulis, 
Neiman et al. 1998, Mekhail, Seebacher et al. 2008, Bystricky, Van Attikum et al. 2009, 
Ruault, De Meyer et al. 2011). Indeed, our results show reduced attachment of the HML 
locus to the nuclear envelope in disome X cells. The diffused Sir2 distribution, particularly 
in cells with desilenced HML gene expression, is consistent with previous reports that the 
silencing function of this protein requires its concentration to perinuclear pools (Hoppe, 
Tanny et al. 2002, Taddei, Van Houwe et al. 2009). However, it is presently unclear 
whether the insufficient tethering of chromosome regions to be silenced to the nuclear 
periphery or failed concentration of Sir2 to this area of the nucleus is directly caused by 
the increased copy number of the relevant genes on Chr X.  Studies of the transcriptome in 
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trisomy 21 human fibroblasts show that, although the overall nuclear organization defined 
by lamin-associated domains (LADs) is intact in these cells, alterations in H3K4me3 
correlate with specialized gene expression dysregulation domains (GEDDs) (Letourneau, 
Santoni et al. 2014). This finding together with our results suggests that a perturbed nuclear 
compartmentalization, which causes changes in gene expression, may be an emergent 
outcome of gene copy number imbalance associated with certain chromosome aneuploidy. 
However, our data do not clarify whether the altered chromatin positioning or HML 
perinuclear localization in disome X strain was a cause or consequence of chromatin 
desilencing.  
Epigenetic states are acquired through a precise balance between euchromatin and 
heterochromatin and are an essential mechanism to control proper cellular identity 
(Jaenisch and Bird 2003). Here, we have shown that numerical alterations in chromosomes 
can derepress heterochromatin to break this delicate balance, relax epigenetic inheritance, 
and cause stochastic variation in cell identity that impairs the responsiveness to regulatory 
factors. Our findings provide the causal evidence that aneuploidy is a source of epigenetic 
instability. It may thus be worth exploring a potential linkage between epigenetic 
dysregulation and chromosome copy number alterations observed in cancer. The 
aneuploidy-induced changes in heterochromatin inheritance and histone-modification 
landscape may be an important mechanism by which chromosomal instability drives large-
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Yeast strains and plasmids: The yeast strains used in this study were generated in the 
S288c background and are listed in Table 1 and Table 4. To construct the parental strain 
RLY9017 (hml::PURA3-NLS-YFP), the RLY2626 strain (MATa, HML, S288c background) 
was crossed with the Y3401 strain (MATα, hml::PURA3-NLS-YFP, W303 background) 
generously provided by James Broach (Xu, Zawadzki et al. 2006). The resulting diploid 
strain was sporulated to obtain a haploid strain with the genotype MATα, hml::PURA3-NLS-
YFP, which was further backcrossed with RLY2626 five times to get a strain background 
congenic to S288c. The resulting haploid strain RLY9017 was then converted to a fully 
isogenic triploid strain carrying HML::YFP by cycles of mating-type switching and mating 
as described in Figure 1 - figure supplement 1A. 
To obtain segregant strains from aneuploid cells, the parental strains were grown in 
synthetic complete (SC) medium (Sunrise Science Products, Inc., San Diego, CA) 
containing 25 µg/ml radicicol (Sigma-Aldrich, Saint Louis, MO) for 12 hours at 30°C and 
then plated on YPD plates at a single-colony density (Chen, Bradford et al. 2012). Single 
colonies were then selected for further analysis based on karyotype. The RLY9029 and 
RLY9031 strains were constructed by transforming the Chr X::Pgal1-URA
KL-CenX cassette, 
amplified from the DY6304 strain generously provided by Rodney Rothstein using primers 
WMP5 and WMP6, into the RLY9017 and RLY9024 strains, respectively (Reid, 
Sunjevaric et al. 2008). The RLY9028 and RLY9030 strains were constructed by 
transforming the Pgal1-URA
KL cassette, amplified from the RLB914 strain using primers 
WMP3 and WMP4, into the RLY9017 and RLY9024 strains. The RLY9033 and RLY9035 
strains were obtained by crossing RLY2627 cells (MATα, HML) with RLY9025 cells 
(MATa, hml::PURA3-NLS-YFP; + Chr X). The resulting trisomy X strain (diploid strain with 
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an extra copy of Chr X) was sporulated and meiotic progenies were selected for genotype 
(HML-WT copy) and karyotype, determined by qPCR, to obtain WT haploid and disome 
X strains. 
The LacO array and LacI-GFP fusion protein have been described previously 
(Robinett, Straight et al. 1996, Straight, Belmont et al. 1996). Briefly, the RLY9041 and 
RLY9042 strains carrying insertions of LacI-GFP and LacO array 1.5 kb proximal to the 
HML locus were obtained by crossing RLY9035 (MATa; +Chr X) cells with the YDB111 
(MATα) strain generously provided by James Haber (Bressan, Vazquez et al. 2004). The 
resulting trisomy X strain was sporulated, and the dissected meiotic progenies were 
selected for genotype (hmlprox::lacO(256)-LEU2; HIS3::PURA3-LacI::GFP-KanMX) by 
growing on SC-Leu+G418 plates. WT haploid and disome X strains were identified by 
qPCR-based karyotyping. PCR-mediated homologous recombination was used to C-
terminally tag SIR2 with HA and mTurquoise2, tag NUP60 with mCherry, and delete SIR1 
by replacing the genomic locus with a KanMX6 cassette (Longtine, McKenzie et al. 1998, 
Sheff and Thorn 2004); correct integrations were confirmed by PCR-based genotyping.  
To construct the plasmid pWM1 (RLB912), ORFs for RPL39 and RPS14B were amplified 
from RLY9017 cells and cloned into EagI and XhoI sites respectively, into the pRS306 
plasmid. To construct the plasmid pWM2 (RLB913), Gibson assembly was used to clone 
the indicated ORFs into the XhoI site of the pRS306 plasmid. The RLY9046 and RLY9047 
strains were constructed by transforming NcoI-digested pWM1 and HpaI-digested pWM2 
into RLY9017 and RLY9018 cells, respectively. To construct the RLY9048 strain, the 
RLY9046 and RLY9047 strains were crossed and sporulated; the dissected meiotic 
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progenies were selected for the indicated genotypes using a standard PCR-based method. 
The plasmids used in this study are listed in Table 5. 
 
Microscopy: To prepare cells for microscopy, yeast strains were grown in SC or drop-out 
medium for about 18 hours at 25°C before the cultures were diluted to a starting OD600 of 
0.2 and grown for another five hours to an OD600 of 0.6-0.8. Fluorescence microscopy was 
performed at room temperature on live cells using a 100× αPlan Fluor NA 1.46 objective 
on a Zeiss Axiovert 200 M microscope (Zeiss, Jena, Germany), equipped with a Yokogawa 
CSU-X1 spinning-disk confocal system. Using 488 or 561 nm illumination to excite green 
or red fluorescent proteins, respectively, a series of optical sections with a step size of 0.5 
µm was acquired with a Hamamatsu C9100 EMCCD camera and MetaMorph acquisition 
software. ImageJ software (v. 1.50e; NIH; RRID:SCR_003070) was used to subtract 
background, adjust contrast, and generate the final sum projections shown.  
Time-lapse imaging was performed on a Perkin Elmer Ultraview VoX system 
(PerkinElmer, Inc., Waltham, MA) or a Zeiss LSM780 laser scanning confocal microscope 
(Zeiss, Jena, Germany) with a 63×/1.4 oil Plan-Apochromat objective and Zeiss Definite 
Focus. To prepare the cells, 10 µl of a mid-log phase culture with an OD600 of 0.5 was 
placed on a thin SC agarose gel pad as described (Tran, Paoletti et al. 2004). Z-stack images 
were acquired with a 0.5 µm step size at 30 min time intervals for 14-18 hours. For each 
time point, images were adjusted using ImageJ software (v. 1.50e; NIH; 
RRID:SCR_003070), converted to maximum Z projections, and analyzed for mean 




Induction of chromosome non-disjunction using galactose: Strains were grown 
overnight in SC + 2% dextrose medium, diluted 2000 times with SC + 2% raffinose 
medium (Sunrise Science Products, Inc., San Diego, CA), and grown to saturation at 25°C.  
Cells were pelleted, washed twice with water, inoculated into SC + 2% raffinose medium, 
and grown until cultures reached log phase with OD600 of 0.6-0.8. Cells were pelleted again, 
washed twice with water, and grown in SC + 2% galactose medium (Sunrise Science 
Products, Inc. San Diego, CA) for nine hours (Anders, Kudrna et al. 2009). To stop 
galactose induction, the cells were pelleted, transferred into SC + 2% dextrose medium 
(Sunrise Science Products, Inc., San Diego, CA), grown for three hours at 25°C, and 
imaged.  
 
Selection of stable aneuploid karyotypes: Strains with stable aneuploid karyotypes were 
selected as previously described (Pavelka, Rancati et al. 2010). Briefly, DNA content was 
analyzed by fluorescence-activated cell sorting (FACS) for eight randomly picked colonies 
derived from each of the desired triploid meiosis-generated spores; strains were only 
selected for further analysis if the DNA content of the eight colonies showed levels of 
variability similar to those of the wild-type control strain RLY9017, indicating uniform 
ploidy. For these strains, DNA content was reassessed as before, using cells that were 
independently revived from frozen stocks three times. Strains that continued to show stable 
ploidy after repeated rounds of FACS analysis were then karyotyped by qPCR.  
 
Illumina whole-genome sequencing: Euploid (RLY9017, RLY9019, and RLY9021) and 
aneuploid (RLY9071, RLY9076, RLY9078, and RLY9079) strains were subjected to 
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whole-genome sequencing. Genomic DNA (gDNA) was extracted from 15 ml of stationary 
phase yeast cultures, using a standard protocol (Hoffman 2001) with the following 
modifications. Three consecutive phenol/chloroform/isoamylalcohol extractions, followed 
by a final chloroform extraction, were performed to reduce protein and phenol 
contamination, respectively. The gDNA samples were then treated with 50 ng/μl affinity-
purified RNase A (Thermo Fisher Scientific, Waltham, MA) for 60 min at 37°C to remove 
contaminating RNA. Final gDNA yields were quantified with a ND-1000 
spectrophotometer (NanoDrop, Thermo Scientific, Waltham, MA). Genomic libraries were 
prepared according to Illumina’s recommendations, except that sonication was used 
instead of nebulization. Cluster generation and read sequencing were performed according 
to Illumina’s recommendations. 150 bp paired-end reads were collected using the Illumina 
MiSeq system (Illumina, Inc., San Diego, CA) and aligned to the UCSC sacCer3 reference 
sequence using the BWA package; RRID:SCR_010910 (Li and Durbin 2009), set at a 
maximum edit distance of 2 per read and allowing for gapped alignment with a maximum 
of 5 gap opens and −5 gap extensions. The genome analysis toolkit 
(https://software.broadinstitute.org/gatk/; RRID:SCR_001876) was used to call variants 
between the reference genome (sacCer3) and each of the strains. Variants were annotated 
using SnpEff (http://snpeff.sourceforge.net; RRID:SCR_005191). We then excluded SNPs 
found across all sequenced strains to eliminate mutations already present in the euploid 
background. All potential mutations were then manually inspected in IGV 
(http://www.broadinstitute.org/igv; RRID:SCR_011793), and SNPs called in repetitive 
regions, in long poly-A or poly-T stretches, or in regions of low alignment quality were 
discarded. All remaining SNPs were verified by reanalyzing each strain using Sanger 
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sequencing. This analysis revealed that there were no mutations in coding regions that were 
not already present in the parental euploid strains. Reads have been deposited in the NCBI 
Sequence Read Archive (SRA; RRID:SCR_004891) under accession no. SRP105283. 
 
RNA-seq analysis: Cells were grown in SC medium for 18 hours at 25°C; cultures were 
then diluted to a starting OD600 of 0.2 and grown for five to six hours to an OD600 of 0.6. 
RNA samples were prepared from ten OD600 units of the final yeast culture using a standard 
acid–phenol/chloroform extraction method (Collart and Oliviero 2001), and contaminating 
gDNA was removed by treating with DNase I (Sigma-Aldrich, Saint Louis, MO).  PolyA-
selected, 50 bp single-end RNA-seq libraries were prepared using the Illumina TruSeq 
stranded mRNA sample prep kit (Illumina, Inc., San Diego, CA), quantified using a 
Bioanalyzer (Agilent, Santa Clara, CA), and sequenced on an Illumina HiSeq 2500 
platform. Reads were aligned to the sacCer3 reference genome using Bowtie software 
(RRID:SCR_005476) with default alignment parameters. Read counts were normalized to 
chromosome copy number. The resulting binary alignment/map (BAM) files were sorted 
and indexed using SAM tools (Li, Handsaker et al. 2009). Differential gene expression was 
evaluated using the edgeR library (Robinson, McCarthy et al. 2010), and adjusted p-values 
were calculated by the Benjamini-Hochberg procedure. Reads and processed data files 
have been deposited in NCBI Gene Expression Omnibus (GEO) under accession no. 
GSE98435. 
 
Quantitative reverse transcriptase-PCR (qPCR) analysis: RNA was extracted as 
described above and cDNA was prepared from 2 µg of the resulting total RNA using the 
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Super-Script III reverse transcriptase kit (Thermo Fisher Scientific, Waltham, MA). qPCR 
was performed using SYBR Green real-time PCR master mix (Quanta Biosciences, 
Beverly, MA) and analyzed by standard procedures (Yuan, Reed et al. 2006). Gene 
expression profiles were normalized to chromosome copy number. The oligos used for 
qPCR amplification are listed in Table 6.  
 
ChIP-seq analysis: Chromatin immunoprecipitation was performed as previously 
described (Aparicio, Geisberg et al. 2005). Briefly, yeast cells were grown in 500 ml of SC 
medium to an OD600 of 0.8–0.9 and were cross-linked with 1% formaldehyde (Sigma-
Aldrich, Saint Louis, MO) for 20 minutes before the chromatin was extracted. The 
chromatin was sonicated using Bioruptor (Diagenode, Denville, NJ) at the high setting for 
ten cycles of 30 sec on/off to yield an average DNA fragment size of 500 bp. Chromatin 
extracts were diluted in immunoprecipitation (IP) buffer and centrifuged to pellet debris; 
the resulting supernatant, containing the chromatin solution, was aliquoted for 
immunoprecipitation as follows. Chromatin was first incubated overnight with antibody at 
4°C, then with Dynabeads® protein G beads (Thermo Fisher Scientific, Waltham, MA). 
Beads were washed several times, and DNA was recovered in elution buffer (1% SDS, 0.1 
M NaHCO3). Crosslinking was reversed by incubating samples at 65°C overnight, 
followed by protease treatment, phenol/chloroform extraction, and ethanol precipitation of 
the recovered DNA. Sequence libraries were constructed and validated using the Illumina 
library protocol and sequenced using the Illumina HiSeq 2500 system as 50 bp single-end 
reads. Reads were mapped to the sacCer3 reference genome using Bowtie software 
(RRID:SCR_005476) with parameters: --best –strata -v2 -m 1. Peaks were called by 
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Model-based Analysis of ChIP-Seq (MACS2) using default settings (Zhang, Liu et al. 
2008), mapped to the closest gene, and kept only if they occurred within 600 bases of the 
transcription start site. Peak scores, defined as the -log10 transformed q-values, normalized 
to chromosome copy number, were converted to Z-scores for comparison across strains 
and plotted as the difference between disome X and WT haploid strains (Figure 6A-B). 
Antibodies used for immunoprecipitation are: anti-HA (12CA5, Sigma-Aldrich, Saint 
Louis, MO; RRID:AB_514505), anti-H3K79me3 (ab2621, Abcam, Cambridge, MA; 
RRID:AB_303215), anti-H3K4me3 (04-745, EMD Millipore, Temecula, California; 
RRID:AB_1163444), and anti-H4K16ac (07-329, EMD Millipore, Temecula, California; 
RRID:AB_310525). Reads and processed data files have been deposited in NCBI Gene 
Expression Omnibus (GEO; RRID:SCR_005012) under accession no. GSE98282. 
 
Pheromone sensitivity assay: For cell cycle analysis, 107 mid-log phase cells were grown 
in SC medium containing 2 µg/ml α-factor (US Biological, Salem, MA) for 90 mins at 
30°C. Cells were then fixed in 70% ethanol and analyzed for DNA content using an Attune 
NxT flow cytometer (Thermo Fisher Scientific, Waltham, MA) as described (Pavelka, 
Rancati et al. 2010). For the halo assay, 15 µl of 2 µg/ml α-factor was applied to filter discs 
centered on a lawn of MATa cells with a WT HML locus. Cells were grown for 2-3 days at 
30°C, and the size of the halo (region devoid of cell growth) was determined as described 
previously (Cherkasova, Lyons et al. 1999).  
 
Gain-of-function screen: 304 of the 356 total Chr X ORFs are available in the Molecular 
Barcoded Yeast (MoBY) ORF plasmid library (Ho, Magtanong et al. 2009) and used for 
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the screen. Each plasmid was extracted and transformed independently into the disome III 
strain RLY9023 (HML::PURA3-YFP) as described previously (Chen, Mulla et al. 2015). 
Transformants were grown in 96-well deep-well blocks containing 2 ml SC-Ura medium 
at 30°C for 12 hours. Cells were then fixed with 1% paraformaldehyde and imaged on the 
Operetta high-content imaging system (PerkinElmer, Inc., Waltham, MA) with a 63×/1.4 
Plan-Apochromat objective. Desilencing scores were calculated as the ratio of the mean 
YFP fluorescence intensity of a test strain carrying a MoBY plasmid to that of the disome 
X strain carrying an empty MoBY vector (RLY9046). 
